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Abstract 
Enzymes enable biocatalysis with minimal by-products, high regio- and 
enantioselectivity, and can operate under mild conditions. These properties facilitate 
numerous applications of enzymes in both industry and research. Great progress has been 
made in protein engineering to modify properties such as stability and catalytic activity of 
an enzyme to suit specific processes. On the contrary, the generation of artificial enzymes 
de novo is still challenging, and only few examples have been reported. The study and 
characterization of artificial enzymes will not only expand our knowledge of protein 
chemistry and catalysis, but ultimately improve our ability to generate novel biocatalysts 
and engineer those found in nature. 
My thesis focused on the characterization of an artificial RNA ligase previously 
selected from a library of polypeptide variants based on a non-catalytic protein scaffold. 
The selection employed mRNA display, a technique to isolate de novo enzymes in vitro 
from large libraries of 1013 protein variants. The artificial RNA ligase catalyzes the 
formation of a phosphodiester bond between two RNA substrates by joining a 5'-
triphospate to a 3'-hydroxyl, with the release of pyrophosphate. This activity has not been 
observed in nature. An initial selection carried out at 23°C yielded variants that were 
poorly suitable for biochemical and biophysical characterization due do their low 
solubility and poor folding. We hence focused our studies on a particular improved ligase 
variant called ligase 10C, isolated from a subsequent selection performed at 65°C. 
Here we report the structural and biochemical characterization of ligase 10C. We 
solved the three-dimensional structure of this enzyme by NMR. Unexpectedly, the 
original structure of the parent scaffold used for building the original library was 
abandoned. The enzyme instead adopted a novel dynamic fold, not previously observed 
in nature. The structure was stabilized by metal coordination, yet lacked secondary 
structural motifs entirely. We also compared the catalytic and thermodynamic properties 
of ligase 10C to enzyme variants previously selected at lower temperature (23°C). Ligase 
10C displayed a remarkable increase in melting temperature of 35°C compared to its 
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mesophilic counterpart. In addition, its activity at 23°C was about 10-fold higher 
compared to the mesophilic variants. This work was the first mRNA display selection for 
catalytic activity at high temperature, and further highlighted the capacity of the 
technique to select for proteins with rare properties. 
To facilitate detailed mechanistic studies of this unnatural enzyme, a crystal 
structure would be essential. Unfortunately, ligase 10C did not form crystals likely due to 
its highly dynamic regions. With the goal of identifying a truncated less flexible version 
of the enzyme that would be more suited for crystallization, we generated a library of 
random deletion variants of ligase 10C and performed an mRNA display selection to 
identify shorter active variants.   
Finally, we describe the attempted selection of an enzyme for the same RNA 
ligation reaction from a completely random polypeptide library. The long-term goal of 
the overarching project in the Seelig lab is to elucidate and compare the structure and 
mechanism of enzymes generated from different starting points, yet catalyzing the same 
reaction, to obtain insights into potential evolutionary pathways.  
In summary, our work revealed the unusual structural and biophysical properties 
of the artificial ligase 10C, and thereby demonstrated the power and flexibility of mRNA 
display as a technique for the selection of de novo enzymes. 
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Chapter 1 : Introduction 
 
Sections 1.3 and 1.4 were adapted from the review article: Golynskiy, M. V., Haugner 
III, J. C., Morelli, A., Morrone, D., and Seelig, B. (2013) In vitro evolution of enzymes. 
Meth. Mol. Biol. 978, 73-92 with permission from Springer Science and Business Media. 
All authors contributed significantly to writing the article. Dr. Burckhard Seelig planned, 
reviewed and edited the manuscript before submission. 
 
Hyperlink to original publication 
http://link.springer.com/protocol/10.1007%2F978-1-62703-293-3_6 
 
Figures 1.3, 1.4, and 1.5 were reprinted from Seelig B, Szostak JW (2007) Selection and 
evolution of enzymes from a partially randomized non-catalytic scaffold. Nature 
448:828-831 with permission from Macmillan Publishers Ltd. 
1.1 Thesis overview 
 Chapter 1 introduces the use and benefits of enzymes in research and industrial 
applications, and highlights the importance of directed evolution in developing tailored 
biocatalysts. Several methods for the evolution of natural enzymes and for the generation 
of de novo enzymes are described. Particular attention is given to an artificial RNA ligase 
previously selected by Dr. Seelig with mRNA display. 
 Chapter 2 describes the selection and characterization of a thermostable variant of 
the artificial RNA ligases. Additional rounds of mRNA display on the variants initially 
isolated at 23°C were performed at 65°C, and a soluble variant termed ligase 10C was 
characterized by biochemical and biophysical assays. A melting temperature of 72°C was 
observed, 24-35 degrees higher compared to two mesophilic counterparts also studied in 
this chapter. Ligase 10C was also active at 65°C, and 8 to 10-fold more active than the 
mesophilic variants at 23°C. 
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 Chapter 3 reports on the solution of the three-dimensional structure of ligase 10C 
by NMR. We observed a new and dynamic fold, which also bound zinc but in a different 
manner than the parent scaffold. We proposed two putative zinc binding sites and a 
putative substrate binding site which corresponded to a region conserved among ligase 
10C and other ligases selected at 23°C.  
 Chapter 4 details the development of a method to create libraries of random 
deletion mutants. The protocol was easier to implement and delivered more consistent 
results than existing procedures employed for the same purpose. The method was tested 
on DNA sequences encoding ligase 10C and the results were analyzed by both next 
generation sequencing and mRNA display. We found that the method created single 
deletions of varying size and position with only a slight bias for deletions at the 3' end. 
The obtained deletion library of ligase 10C was used as input in an mRNA display 
selection that led to the isolation of two active N-terminal deletion variants.  
 Chapter 5 describes experiments aimed at selecting an RNA ligase from a 
completely random library. We first optimized the efficiency of all the steps of the 
selection protocol for high yield and purity of the mRNA displayed proteins and then 
performed a selection for 13 rounds. Selection progress indicated that no active variants 
were enriched. Results were verified by sequencing the DNA from the final round of 
selection and screening of isolated clones. We are currently in the process of repeating 
the selection under modified conditions that might increase the chance for folding and 
activity, yet, as this project is work in progress the results will not be part of this thesis.  
 The final section of the thesis presents conclusions and future directions for 
mRNA display and artificial enzyme selections in general, and for specific projects in the 
Seelig lab. 
1.2 Significance 
1.2.1 The benefits of new enzymes 
Enzymes are catalysts capable of performing reactions with minimal by-products, 
and regio- and enantioselectivity, under very mild conditions. Given these favorable 
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characteristics, biocatalysis has been employed in various industries, from food to 
pharmaceutical manufacturing, as a cheaper and environmentally friendly alternative to 
chemical catalysis [1]. 
For example, enantiopure β-amino acids are important building blocks of drugs 
such as the anti-cancer taxol, and β-lactams, which are employed in the production of 
antibiotics. The chemical synthesis of β-amino acids involves a high metal catalysts load, 
and hazardous materials. On the other hand, enzymatic catalysis with transaminases 
offers high selectivity, broad substrate specificity [2], and an enantiomeric excess as high 
as 99% [3] without hazardous waste. While biocatalysis already plays an important role 
in the pharmaceutical industry, it was argued that in the future its importance will 
increase in this sector [4]. Biocatalysis, along with metabolic engineering, will have 
central roles in multidisciplinary platforms aimed at the manufacturing and discovery of 
new drugs directed at previously unaddressed targets [4]. 
Enzymes also have several applications in the food industry. Amylases, are 
commonly used to break down starch, in the production of high fructose corn syrup, for 
brewing, baking [5], and in detergents [6]. Proteases among other enzymes are added in 
detergents, and are also employed in cheese production and meat tenderizing. Pectinases 
increase yield and favor juice clarification in wine and fruit juice production [5]. 
Another area of increasing importance of biocatalysis is energy production: 
demand is expected to increase by 53% in year 2030, and the decrease in fossil fuel 
availability, climate change, and increasing oil price has driven the exploration of 
alternatives such as biofuels [7]. Enzymes like cellulases and lipases are crucial in the 
biofuel manufacturing from cellulose and microalgae. While production processes still 
need improvement, there is great potential to provide energy sources cheaper and greener 
than fossil fuels and first generation biofuels [7,8] . 
Finally, enzymes have been employed as tools in molecular biology, allowing 
major advances in basic science. Application of a thermo stable polymerase [9] 
simplified the execution of the polymerase chain reaction [10], because it was no longer 
necessary to replace the enzyme at end of each cycle. Ligases and nucleases allowed the 
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development of recombinant DNA technology [11], and proteases are crucial in 
proteomics applications from sequencing to protein-protein interaction network discovery 
[12]. High fidelity polymerases have enabled more accurate DNA amplification, hence 
they are employed in sample preparation for genome sequencing [13,14]. In addition, the 
introduction of nucleases such as CRISPR and TALENS [15] permitted accurate editing 
of large eukaryotic genomes. In particular, CRISPR hold great therapeutic promise for 
curing diseases at the genetic level [16]. 
 
1.2.2 Biocatalysis and the impact of directed evolution  
All the applications previously described have been possible because of several 
discoveries and technological improvements that occurred in the last fifty years; however 
the use of enzymes for practical purposes can be dated farther back in time. 
Biotechnology and biocatalysis have been employed since the early history of humanity 
in alcohol fermentation, bread baking and tanning, as witnessed by Egyptian drawings 
reporting of such applications [17], or by treatises describing wine production in the 
roman empire during the second century BC [18]. 
Nonetheless, the foundations of modern biocatalysis were laid only in the early 
19th century with several observations and discoveries that led to the use of isolated 
enzymes and cell extracts in biotechnology [19]. During the first half of the 20th century 
enzymes purified from their host organisms were employed in biotechnology 
applications, however extraction was tedious, yields were often low, and methods to 
improve enzymatic properties were not available [20]. Later, the introduction of 
recombinant DNA technology [11] allowed the production of large amounts of the 
desired protein through heterologous expression. Subsequently, the advent of site-
directed mutagenesis [21], enabled the first examples of rational engineering, with 
success in increasing thermal stability [22] and altering substrate specificity [23]. 
Random mutagenesis with chemical agents or mutator strains was also employed in 
enzyme engineering [24-26]. However this approach presented several disadvantages 
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such as harm to the host organism, off-target mutations [27], and modification of a 
limited set of amino acids [28].  
Despite success achieved with engineering several enzymes and their 
commercialization, in the early 1990’s there were still technical limitations [20]. Building 
libraries of mutants through random mutagenesis was difficult, and it was argued [29,30] 
that properties such as catalytic activity and stereo selectivity were too complex and not 
understood well enough to be engineered systematically and reproducibly through site-
directed mutagenesis.  
However, random mutagenesis was facilitated by the development of mutagenic 
PCR [31]. Soon after the introduction of this procedure, pioneering papers were 
published by Francis Arnold, describing several rounds of mutagenic PCR, each followed 
by screening, which led to the evolution of a protease to function in an organic solvent 
[32]. This iterative process of mutation and selection was termed directed evolution and 
became soon a standard approach for enzyme engineering.  
Usually directed evolution was conducted in vivo. However, towards the end of 
the decade, in vitro methods were developed. These methods had two main advantages 
over in vivo methods: they were not constrained by the need to maintain the host 
organism viability, permitting a wider range of conditions, and library size was not 
limited by transformation efficiency, hence a larger sequence space could be sampled. 
These methods and their applications will be the focus of the following sections of this 
chapter, and particular attention will be given to mRNA display. A more general 
discussion of directed evolution can be found elsewhere [19,20,27,33,34] 
1.3 Evolving enzymes in vitro 
 In vitro enzyme evolution offers a means to engineer enzymes by exploring 
enormous libraries of protein variants that exceed the capabilities of in vivo methods. The 
development of cell-free protein production systems made it possible to evolve enzymes 
outside of cells, in a test tube. In vitro evolution techniques have been used to improve 
existing enzymes and, in addition, have enabled the generation of biocatalysts de novo 
from a non-catalytic protein library [35]. 
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 All methods used for enzyme evolution require that each protein in a pool of 
mutants can be traced back to its encoding gene for identification, and potentially for the 
purpose of amplification, expression and further evolution [36]. A stable genotype-
phenotype linkage allows for many enzyme variants to be mixed in a single reservoir 
while maintaining the ability to amplify genes of individual desired variants. Those 
variants are isolated from the reservoir using suitable screening or selection approaches. 
In the case of in vivo evolution methods, the genotype and phenotype are linked as the 
protein and its gene are contained in the same cell. With partial in vitro methods, proteins 
are translated by the host’s cellular machinery and then displayed in an extracellular 
fashion, for example on the surface of a phage in the phage display approach. In contrast, 
the methods described here are carried out entirely in vitro and do not require any step to 
be performed inside a host cell. The crucial genotype-phenotype link is maintained 
through either a direct physical link or through artificial compartmentalization.  
 
1.3.1 Benefits of in vitro evolution 
 In vitro methodologies have several advantages over in vivo and partial in vitro 
methods because they are not limited by cell survival, growth, or function. The three 
main advantages are: (1) the ability to work with larger libraries of variants, (2) the 
tolerance to conditions that would be deleterious to cell survival, and (3) the ability to 
directly manipulate the DNA after each round of evolution.  
 As in vitro evolution is not dependent on library transformation into a host, the 
number of unique sequences that can be evaluated in a single experiment exceeds in vivo 
approaches. The largest reported in vitro libraries contain 1014 DNA sequences [37]. By 
comparison, phage display libraries produce up to 1010 unique variants in a single 
transformation [38]. Library sizes up to 1012 variants were reported for phage display by 
the pooling of dozens of separate transformations, but such scale-up may not be feasible 
for most laboratories [39]. Most typical library sizes for in vivo selections are between 
106 and 108 variants. Because in vitro evolution can search a larger sequence space, it is 
particularly well suited for isolating beneficial enzyme mutations that may be very rare. 
 7 
 
 The evolution of enzymes in vitro greatly expands the range of substrates and 
environmental conditions that can be investigated. The presentation of substrate to the 
enzymes is simplified as no cell walls have to be crossed, which are impermeable to 
many potential substrates. Most importantly, substrates and enzymes can be used that 
would be toxic to a cell [40]. Furthermore, enzymes can be engineered with in vitro 
methods for increased stability under extreme conditions of pH, temperature, ion 
concentration, or in the presence of denaturants or organic solvents. In vitro evolution 
also allows for a more accurate representation of enzyme performance. Cellular 
evolution, in contrast, can generate complex phenotypes that falsely suggest increased 
activity through increased enzyme accumulation, rather than improved catalysis [41].  
 Finally, in vitro evolution allows for direct manipulation of the DNA library 
between each round of evolution. Unlike in vivo methods that require time-consuming 
purification of the target gene, DNA from in vitro evolution is amplified directly through 
PCR. This facilitates the introduction of diversity through methods like error-prone PCR 
or in vitro recombination. In comparison, in vivo methods may introduce genetic diversity 
by using microbial strains deficient in DNA repair pathways to eliminate the need for 
DNA purification. However, these mutations may occur anywhere in the genome, 
necessitating a low mutation rate for continued survival [42]. Thus, by combining a 
selection or screen with methods to add genetic diversity, full Darwinian evolution can be 
carried out more conveniently in vitro.  
 While in vitro evolution greatly expands the tools available for the creation and 
engineering of new enzymes, in vivo approaches have certain advantages, too. As in vitro 
methods require purification of the genotype/phenotype components, in vivo evolution 
may involve fewer discrete steps. Furthermore, some enzymes are being developed for in 
vivo use, such as enzymes that need to function within a metabolic pathway. Those 
enzymes could initially be evolved in vitro, but ultimately need to be evolved in their 
native environment to optimize their intracellular compatibility. Thus, the two approaches 
can complement each other. 
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1.3.2 General workflow for in vitro methods  
 All in vitro directed evolution methods follow a similar scheme. The initial DNA 
library encoding the protein variants is transcribed and translated, either sequentially or in 
a one-pot reaction. Next, the genotype-phenotype link and then genotype-phenotype-
substrate link is established. This may be accomplished through a physical connection 
(ribosome display, mRNA display, and DNA display), or through compartmentalization 
(IVC, IVC-based DNA and microbead displays) (Figure 1.1). Active enzyme variants 
that convert substrate to product result in co-localization of genotype-phenotype with 
product and are then isolated by screening or selection. Finally, the genotype is recovered 
and either analyzed directly by sequencing or subjected to additional diversification for 
subsequent rounds of evolution. 
 
Figure 1.1-Overview of methods for the in vitro selection or screening of proteins discussed in this 
review. 
(A) The top row shows different strategies to establish the crucial linkage between gene and protein. (B) 
The bottom row illustrates the introduction of substrate into the selection scheme to enable the evolution of 
enzymes. 
 
1.3.3 Library construction 
 In any directed evolution procedure, the size and quality of the starting DNA 
library are of great importance as they affect the probability of finding the desired 
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mutant. Although in vitro selection methods can sift through comparably large libraries 
of trillions of mutants, the sheer size of the protein sequence space prevents us from 
sampling more than an exceedingly small fraction of all possibilities. For example, the 
largest protein libraries used to date contain about 1013 variants (Table 1.1). This vast 
number of mutants will just be enough to include one molecule of all possible 
combinations for a sequence of ten amino acid positions. In comparison, most natural 
proteins are more than 100 amino acids in length. Therefore, libraries of mutants should 
be designed wisely to increase the chances of success in a directed evolution experiment. 
Accordingly, one should consider randomizing specific amino acid positions by using 
degenerate codons. Instead of randomizing positions with NNN codons (N=A,C,G,T), 
NNK codons (K=G,T), NNS codons (S=C,G) or even a reduced alphabet of NDT codons 
(D=A,G,T) can be used to reduce oversampling caused by codon degeneracy [43]. The 
use of degenerate codons can also reduce the likelihood of introducing unintended stop 
codons. For example, the NNN codon includes three stop codons whereas the NNK or 
NNS codons include only one. Alternatively, a given library can be assembled from 
fragments that have been pre-selected to decrease the occurrence of premature stop 
codons [37]. More recently, DNA synthesis via phosphoramidite trinucleotides has 
become commercially available [44]. Codon by codon synthesis using trinucleotides 
offers full control of the library composition by defining the set of desired amino acid 
mutations at any position while avoiding stop codons [45].  
 
Table 1.1- Comparison of in vitro technologies.  
Method Genotype-phenotype 
link 
Reported variants 
in single experiment 
Results 
Ribosome display Non-covalent complex 
of mRNA-ribosome-
protein  
~1013 Proof of concept selections for 
sialyltransferase [46], beta-
lactamase [47], dihydrofolate 
reductase [48], DNA ligase [49] 
and sortase [50]  
mRNA display Covalent fusions of 
mRNA-protein via 
puromycin 
~1013 Selection for de novo RNA ligase 
[51,52] 
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DNA display  Covalent or non-
covalent complex of 
DNA-protein  
~1012 Proof of concept selection of 
binders, but no enzymes [53,54] 
In vitro 
compartment-
talization (IVC) 
Spatial confinement ~109 (selection) 
~106-108 (screening 
by 
FACS/microfluidics) 
Selection for methyltransferase 
[55] and restriction nuclease [56];  
Proof of concept screening for β–
galactosidase [57,58] 
IVC & microbead 
display 
Non-covalent complex 
of DNA-microbead-
protein  
~109 (selection) 
~106-108 (screening 
by 
FACS/microfluidics) 
Screening for phosphotriesterase 
[59]; 
Proof of concept screening for 
hydrogenase [60]; 
Proof of concept selection of 
biotin ligase [61] 
IVC & DNA 
display  
Covalent or non-
covalent complex of 
DNA-protein  
~108-109 
 
Selection of antibodies as 
heterodimers, but no enzymes [62] 
 
 In order to use a DNA library for a specific in vitro evolution technique, the 
sequences at both termini of the DNA have to be made compatible to the method of 
choice. The 5’-end includes promoter and enhancer sequences necessary to facilitate 
transcription and translation, respectively. The nature of these sequences depends on the 
type of transcription and translation system used. Other sequence elements might be 
included such as a terminator, stabilizing hairpins, affinity purification tags or sequences 
that are specific to the particular in vitro evolution method [63].  
1.4 Methods for in vitro directed evolution 
1.4.1 Ribosome display  
 The ribosome display technology creates the genotype-phenotype linkage through 
a ternary complex of a stalled ribosome, the translated protein and its encoding mRNA 
(Figure 1.1). The complex is stabilized by high magnesium concentrations and low 
temperatures. Ribosome display was initially described for the purification of specific 
mRNA sequences based on immunoprecipitation of the encoded protein [64]. 
Subsequently, this method was developed further to select and evolve peptides and 
proteins [65,66]. Although ribosome display has mostly been used for selection of 
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binders, several model selections for enzymatic activity have been reported and will be 
reviewed here in more detail.  
 Several criteria must be met in order to generate ribosome-displayed proteins. 
Most importantly, the terminal stop codon of the gene of interest must be removed. This 
will prevent the ribosome from dissociating and releasing the nascent protein and will 
instead promote stalling of the ribosome and therefore maintain the ternary complex. 
Stem-loop structures are often added to flank the gene on both termini to increase RNA 
stability during translation and subsequent manipulations. Since the protein is not 
released from the ribosome, a C-terminal protein spacer (>100 amino acids) is added to 
ensure that the displayed protein has exited the protein-conducting channel of the 
ribosome and can fold properly. Typically, ribosome-displayed proteins are generated 
through sequential transcription and translation, as coupled transcription/translation 
systems can result in 100-fold reduced protein yield [65,67]. The translation is stopped by 
decreasing the temperature and increasing the Mg2+ concentration to stabilize the ternary 
complex. To maintain the genotype-phenotype linkage, the subsequent selection process 
also has to be performed at low temperatures and in presence of elevated Mg2+ 
concentrations. The ribosome-displayed proteins are mostly used in selections without 
any additional purification. The RNA is recovered after the selection by dissociating the 
ternary complex through chelation of Mg2+ with EDTA. 
 Ribosome display has been utilized in a number of model selections for enzymatic 
activity. Most selections were performed by selecting for binding to an immobilized 
substrate, substrate analog, or inhibitor. These model selections demonstrated enrichment 
of the desired enzyme (10 to 100-fold per round of selection) compared to an inactive 
control (Table 1.1) [46,48-50]. While enzyme selection strategies based on binding can 
be successful in isolating enzymes with known properties (e.g. searching through 
metagenomic libraries for a desired activity), they are not well suited for changing 
substrate specificity or substantially improving activity [33,68]. In one example of a truly 
product-driven model selection, ribosome display has been employed for isolation of a 
T4 DNA ligase [49]. Active enzymes able to ligate a DNA adaptor to the 3’-end of their 
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encoding mRNA were selectively amplified via an adaptor-specific primer and were 
enriched 40-fold over known inactive mutants. Similar to this selection approach, the 3’-
end of the mRNA could be used for the attachment of alternative substrates which would 
allow for a selection of other catalysts by ribosome display.  
 
1.4.2 mRNA display. 
  mRNA-displayed proteins are covalently attached to their encoding mRNA via 
the small linker molecule puromycin (Figure 1.1) [69,70]. Central to the mRNA display 
method is the modification of the stop codon-free 3’-end of the messenger RNA with a 
puromycin-containing DNA linker prior to translation [71,72]. During the subsequent in 
vitro translation, the ribosome synthesizes the polypeptide until it reaches the DNA-
puromycin-modified 3’-end of the mRNA where it stalls. Puromycin, which is an 
antibiotic that mimics the aminoacyl end of tRNA, enters the ribosome and becomes 
covalently attached to the C-terminus of the nascent polypeptide. The resulting mRNA-
displayed proteins are typically purified from unfused proteins and mRNA using 
purification tags. The mRNA-displayed proteins are reverse transcribed to produce the 
cDNA. Reverse transcription also minimizes potential RNA secondary structure and 
increases RNA stability. Detailed protocols on mRNA display have been published 
recently [52,73,74]. Through slight modifications of the mRNA display protocol, 
covalent fusions of protein and encoding cDNA can be generated (cDNA display) 
[75,76].  
 In section 1.5.2 of this chapter we will describe in more details the de novo 
selection of an enzyme by mRNA display, starting from a zinc finger non catalytic 
scaffold [51]. This is so far the only published report of de novo enzyme selection by in 
vitro directed evolution, and the characterization and evolution of the resulting enzyme 
constitutes the basis of my thesis. 
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1.4.3 In vitro compartmentalization (IVC) 
  Directed evolution by in vitro compartmentalization mimics in vivo evolution 
inside a cell by using water-in-oil emulsions to enclose proteins and their encoding DNA 
within the same droplet compartment thereby creating the genotype-phenotype link 
through spatial confinement [77]. IVC has been employed not only in several model 
enzymes selections, but also to improve the performance of existing enzymes through 
screening and selection methods. 
 Compartmentalization by droplet formation is achieved by stirring an aqueous 
solution of genes and a coupled transcription/translation (TS/TL) system into a mixture of 
mineral oil and surfactants [78]. The DNA concentration is chosen such that the average 
droplet contains no more than a single gene. The low volume of the droplets (5-10 
femtoliters) corresponds to a low nanomolar concentration of the single DNA molecule, 
which is efficiently transcribed and translated inside the droplet [58,77,79]. Although 
droplet composition is similar across different IVC experiments, in some cases the 
oil/surfactant mixtures need to be optimized for compatibility with the specific TS/TL 
solution used and the enzymatic activity that is being evolved [77,80]. It has been shown 
that the droplets are stable up to 100°C for many days and do not exchange DNA or 
protein between each other [77,81].  
 IVC-based selections have been used to evolve enzymes that process nucleic acid 
substrates. Here, the encoding DNA is also the substrate for the enzyme and the selection 
is dependent on successful DNA modification. In one approach, the activity of the 
methyltransferase (M.HaeIII) was improved toward a non-native, although already 
recognized, DNA sequence [55]. A library of variants of M.HaeIII was made by mutating 
the DNA contacting residues. The 3'-end of the DNA library was modified with a biotin 
moiety and connected to the remaining gene via the target methylation site that can be 
cleaved by endonuclease NheI unless the site is has been methylated by M.HaeIII. 
Therefore, only methylated genes were not cleaved by NheI and were captured on 
streptavidin beads. A similar approach was used for the model selection of a restriction 
endonuclease activity from a randomized library of the restriction enzyme FokI. Three 
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specific residues were randomized in the catalytic domain, and cleavage sites for FokI 
were introduced in the 3'-UTR [56]. Only the genes coding for an active FokI variant 
were cleaved and captured on beads after incorporation of biotinylated deoxyuracil 
triphosphate at the cohesive ends generated by the restriction enzyme. 
 The IVC methodology has also been used in combination with screening 
approaches. This allows for the evolution of enzymes for non-nucleic acid related 
reactions, but also reduces the number of mutants that can be interrogated compared to 
selection strategies. In the screening approach, either fluorescence activated cell sorting 
(FACS) or microfluidics-based droplet sorting are used to separate active and inactive 
enzymes based on the conversion of non-fluorescent substrate into fluorescent product. 
For FACS mediated screening, water-in-oil-in-water emulsions (double emulsions) are 
generated since FACS instrumentation is incompatible with oil as the main medium [82]. 
Exploiting this principle, the very low β-galactosidase activity of the Ebg enzyme from E. 
coli was increased at least 300-fold by in vitro evolution using a commercially available 
fluorogenic substrate [58]. Recently, the same researchers reported a model enrichment 
of β-galactosidase using a home-made microfluidic system [57]. Although the throughput 
in the microfluidic system is about 10-fold less than in FACS-based screening, this loss is 
offset by other advantages. First, the microfluidic system generates highly monodisperse 
droplets, enabling quantitative kinetic analysis [57,83]. Second, the authors utilized 
microfluidic components that allowed them to fuse droplets together and introduce new 
content into droplets. This conferred multiple benefits as the authors were able to perform 
emulsion PCR in droplets and then merge them with droplets containing the TS/TL mix. 
By generating about 30,000 gene copies per droplet prior to TS/TL, low enzymatic 
activity is more likely to be detected due to the elevated enzyme concentration [57]. 
Furthermore, reagents can be readily added to the droplets after translation, in case the 
translation conditions are not compatible with enzymatic assay [84]. The use of 
microfluidics is a promising route for IVC-based enzyme engineering due to the 
modularity and potential for customization of individual components. However, in 
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contrast to commercially available FACS instruments, assembly of microfluidics devices 
still requires substantial expertise. 
 IVC has also been used in conjunction with in vivo enzyme evolution by 
generating compartments that contain cells. To keep the focus of this review we are not 
discussing this in vivo application. 
 
1.4.4 DNA display  
 Strategies that either directly or indirectly establish a physical link between the 
DNA and the encoded protein are referred to as DNA display (Table 1.2). Although 
several different DNA display methods have been developed, only the IVC-mediated 
microbead display has been used to evolve enzymes. This method generates the 
genotype-phenotype link through the capture of DNA and its translated protein onto the 
same streptavidin-coated microbeads inside a droplet (Figure 1.1) [59,60]. This approach 
requires multiple biotinylated reagents such as primers, antibody and reaction substrate in 
order to capture the template DNA, the protein modified with an epitope tag and the 
substrate onto the microbead, respectively.  
 Using microbead display, Tawfik and Griffiths improved the catalytic 
performance of an already very efficient phosphotriesterase enzyme 63-fold (kcat > 105 s-
1) through FACS-based screening [59]. This work demonstrated the ability to generate, 
break and regenerate the IVC droplets and purify the genotype-phenotype-product 
attached to the microbeads. Furthermore, a substrate was used that carried a photo-caged 
biotin. Therefore, the substrate stays in solution until the biotin is uncaged, which causes 
the immobilization of substrate and resulting product on the beads. Incubation with a 
fluorescent product-specific antibody enabled the specific labeling and isolation by FACS 
of only those microbeads to which functional enzymes and their coding DNA were 
attached [59].  
 In a different proof of concept experiment, a modified microbead display protocol 
was performed as a selection instead of a screen, thereby potentially harnessing larger 
library sizes [61]. In this experiment, an active biotin ligase was enriched from a mixture 
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of inactive genes. Following product formation and immobilization, the purified 
microbeads were incubated with product-specific antibodies that were conjugated to a 
cleavable, gene-specific PCR primer instead of a fluorophore. Re-emulsification and 
droplet PCR with a solution lacking this primer resulted in a 20-fold enrichment of the 
desired genes.  
 Another microbead display model screen employing FACS used an indirect 
readout for activity to isolate [FeFe] hydrogenases [60]. Because the hydrogenase activity 
(H2 breakdown) is difficult to measure directly, the authors employed a redox-sensitive 
dye that can generate a fluorescent signal. Purified microbeads carrying the immobilized 
DNA and enzymes were re-compartmentalized in the presence of the redox dye. This dye 
was modified with a C12-alkyl chain and therefore interacts non-specifically with the 
hydrophobic polystyrene beads. Hydrogenase activity resulted in fluorescence of the dye 
and enabled flow cytometric sorting of the microbeads to recover the DNA of active 
enzymes, yielding a 20-fold enrichment over inactive genes. This proof of concept study 
used microfluidics to generate mono-disperse droplets and microbeads with a larger 
diameter (5.6 µm rather than 1 µm) to increase the bead surface allowing more 
fluorescent substrate to bind, thereby improving the signal to noise ratio. The indirect 
readout as described here could be applied to other screening strategies if 
environmentally sensitive fluorophores are available (pH, redox potential). 
 Presently, only microbead display has been employed to evolve enzymes. Yet 
other DNA display methods could potentially be used for this purpose. In contrast to 
microbead display, all other DNA display methods directly attach the protein to its 
encoding gene via a fusion protein which binds to a specific DNA sequence within the 
parent gene or to a small molecule attached to the parent gene (Table 1.2). The IVC 
method is often used in conjunction with DNA display as the physical genotype-
phenotype linkage allows for the microcompartments to be broken up and generated 
again in order to introduce new components into the system (e.g. substrates). However, 
two proof-of-concept studies conducted without IVC demonstrated the production of 
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DNA-displayed proteins solely by incubating templates with the E. coli cell extract 
[53,54].  
Table 1.2- DNA display methods 
Only the microbead display has been used to evolve enzymes. 
Method Principle of attachment DNA - point of 
attachment 
Protein fusion 
partner 
Microbead 
display [59-61] 
Non-covalent binding of DNA to 
streptavidin microbead and of HA-tagged 
protein via anti-HA antibody to same bead, 
IVC is needed 
Biotinylated HA-tag 
STABLE 
[62,85] 
Non-covalent attachment of protein to 
DNA,  
IVC is needed  
Biotinylated Streptavidin 
CIS-display 
[53] 
Non-covalent attachment of protein to 
DNA 
RepA gene DNA replication 
initiator (RepA) 
Covalent DNA 
display [86,87] 
Covalent attachment of enzyme to suicide 
inhibitor that is linked to DNA, IVC is 
needed 
Modified with 
5-fluoro-
deoxycytidine 
HaeIII 
methyltransferase 
Covalent 
antibody display 
[54] 
Covalent attachment of enzyme to DNA P2A gene Endonuclease P2A 
SNAP display 
[88,89] 
Covalent attachment of enzyme to suicide 
inhibitor that is linked to DNA, IVC is 
needed 
Modified with 
benzyl guanine 
SNAP-tag 
1.4.5 General principles and comparison of different in vitro methods 
The types of reactions catalyzed by enzymes can be divided into transformation 
reactions, bond-forming reactions and bond-breaking reactions (Figure 1.2A). Depending 
on the reaction type, the strategy by which enzymes can be selected varies slightly. In 
general, affinity selections are used to isolate enzymes by methods that create a physical 
link between phenotype and genotype such as ribosome display, mRNA display and 
DNA display (Figure 1.1 and Figure 1.2B). To enable an enzyme affinity selection, the 
substrate has to be linked to the gene-enzyme complex. Enzymes for a transformation 
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reaction can then be isolated if a product-specific affinity reagent, such as an antibody, is 
available (reaction type 1). Via the antibody, the ternary complex of product, active 
enzyme and gene is separated from inactive variants through immobilization. In the case 
of an affinity selection for bond-forming enzymes (reaction type 2), the second substrate 
carries a selectable moiety. Only proteins that catalyze the bond formation between two 
substrates will attach this moiety to the gene-protein-substrate complex and can therefore 
be isolated. For bond-breaking reactions (reaction type 3), the whole complex of gene, 
protein and substrate is immobilized via the substrate and only variants that cleave the 
bond will be released and selected. In contrast to affinity selections, the IVC 
methodology mostly employs fluorescent screening to isolate evolved enzyme variants 
either by FACS or microfluidics (Figure 1.2C and D). This can be achieved if the product 
of the reaction becomes fluorescent or a fluorescent product-specific antibody is 
available. Alternatively, the second substrate, which will be attached in a bond-forming 
reaction to the gene-microbead-substrate-complex, is fluorescent.  
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Figure 1.2-Isolation of enzymatic activities using in vitro technologies. 
(A) Types of enzymatic activities that can be evolved using in vitro approaches. (B) Affinity selection of 
physically linked gene-substrate/product conjugates. The enzyme itself is also linked to the gene-substrate 
complex, but is omitted from the figure for improved clarity. (C) Screen of IVC droplets that become 
fluorescent as a result of catalysis by the enzyme (not shown) contained in same compartment. Separation 
is achieved through fluorescence activated cell sorting (FACS) or microfluidics. (D) Screen for enzyme 
catalysis by FACS of IVC droplets containing microbeads. The enzyme contained in each compartment is 
not shown to improve clarity. Numbers in brackets refer to the type of activity as shown in (A).  
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 For any enzyme evolution experiment regardless of which methodology is used, 
the specific selection or screening strategy has to be customized with respect to the 
underlying reaction. In the case of affinity selections, the need to link the substrate to the 
gene-complex without substantially changing the nature of the substrate can be 
challenging especially for small substrates. On the other hand, suitable fluorophores that 
enable the screening of IVC droplets might not be compatible with some types of 
chemical reactions.  
 Two important questions have to be considered when deciding on which enzyme 
evolution strategy to use: Is the desired mutant potentially very rare such as a mutant 
exhibiting a novel activity? Or, alternatively, is the goal of the evolution experiment to 
generate a highly proficient enzyme? Selection strategies can search larger libraries and 
are therefore more likely to discover rare mutants, compared to screening approaches. At 
the same time, affinity selections only select for a single turnover event and cannot 
evolve an enzyme for high substrate affinity as the substrate is linked to the enzyme and 
therefore present at a high local concentration. In contrast, IVC-based screening methods 
can directly evolve an enzyme for high turnover and substrate affinity, yet, the library 
size of screening methods is several orders of magnitude smaller than those of selections. 
Therefore, it might be most beneficial to combine the two strategies and first use an 
affinity selection method to isolate potentially rare enzyme variants with altered activity 
or substrate specificity and then switch to an IVC-based screening method to optimize 
enzymatic proficiency. 
1.5 De novo enzymes by computational design and in vitro directed evolution 
In most of the directed evolution experiments, mutations are introduced into an 
existing enzyme to improve its properties: activity or stability. However, if a protein with 
the desired activity does not exist in nature, the activity needs to be generated de novo. 
Two approaches have been employed so far to obtain novel enzymes: in vitro selection 
[51], and computational design [90-97]. 
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1.5.1 De novo enzymes by computational design 
Computational design is a rational approach which requires detailed knowledge of 
the targeted reaction. The elucidation of the catalytic mechanism constitutes the starting 
point of any computational design experiment. Subsequently, different active site 
conformations are designed to fit the transition state. Finally, the active site 
conformations are matched combinatorially to several protein scaffolds that can 
accommodate the active site, to generate hundreds of thousands of structures. Powerful 
software, such as the Rosetta software [98], allow to generate these structures quickly, 
and to evaluate them for optimal packing and geometry of the active site. The procedure 
described above is usually performed in four steps [99]: 
1) Definition of target reaction and catalytic mechanism 
2) Modeling of an ideal active site, called theozyme, by quantum mechanics, in 
order to stabilize the transition state 
3) Docking of the theozyme into a scaffold protein, followed by in silico 
mutagenesis to further stabilize the transition state and improve packing 
4) Computational evaluation of the obtained structures regarding geometry of the 
active site and binding energy of the transition state, with subsequent 
experimental evaluation of the top scoring structures 
Several de novo enzymes, such as a retro-aldolase [92], Diels-Alderase [94], and Kemp 
eliminase [93], have been obtained through computational approaches. These enzymes 
usually possessed low activity. However, improvements could be obtained, by further 
modeling [100] and by in vitro directed evolution [95]. For example, the Kcat/Km of 
several retro-aldolase designs was improved as high as 88-fold by changing design 
strategy, and subsequent directed evolution led to improvements of 1100 and 1300-fold 
[95]. In another report, the catalytic efficiency of a Diels-Alderase activity was improved 
18.5-fold, through further computational modeling, by addition of 24 residues which 
turned a 13 residue loop into a helix-turn-helix motif [100]. These examples show that 
combination of de novo enzyme design and directed evolution offer the potential to 
improve novel enzymes with low activities.  
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1.5.2 De novo enzymes by in vitro directed evolution 
The in vitro selection technology mRNA display was used to generate the first de 
novo enzyme through directed evolution [51]. The starting library was composed of 1013 
members. On the other hand most directed evolution techniques sample libraries made of 
to 1010 proteins, severely limiting the possibility of finding rare variants. 
The input library of protein variants was based on a zinc finger non-catalytic 
scaffold. Two loops composed of nine and twelve amino acids each were randomized to 
introduce genetic variation. A 5'-triphosphate dependent RNA ligase was selected, which 
catalyzes the ligation of two RNA strands, forming a 5'-3' phosphodiester bond, and 
relies on a splint oligonucleotide to align the two substrates (Figure 1.3). 
 
Figure 1.3-Splinted ligation of RNA with a 5' triphosphate releasing pyrophosphate [51] 
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Figure 1.4-General scheme for the selection of bond-forming enzymes. [51] 
Substrate A is attached to the reverse transcription primer and substrate B is modified with an anchor 
group. Ligation of A and B results in a covalent link between the cDNA and the anchor group. The cDNA 
of active clones can then be separated from that of non-active clones because they are not capable of 
ligating A and B. 
 
 
The mRNA display procedure involved several steps (Figure 1.4). The input 
library was transcribed into RNA, which was modified with puromycin, and upon 
translation a stable link was obtained between the RNA and the protein it encoded for, as 
explained in section 1.4.2. The obtained mRNA displayed proteins (fusions) were then 
purified, and reverse transcribed with a primer attached to substrate A, in this case a 5'-
PPP RNA oligo (see Figure 1.3). After further purification, fusions were incubated with 
the second substrate, a 3'-OH RNA modified with biotin. Ligation of the two substrates 
by active enzymes resulted in a covalent link between the cDNA and the biotin group. 
The cDNA of active clones was immobilized on a streptavidin resin and separated from 
the cDNA of inactive clones, which were incapable of forming the crucial link between 
their encoding cDNA and the biotin group. The DNA recovered at the end of each round 
was then PCR amplified to reintroduce the promoter region and the whole cycle of 
selection and amplification was repeated until the library was enriched with the active 
variants.   
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After 17 rounds of selection and evolution (by error prone PCR and 
recombination), all but 8 out of 49 clones (83%) had mutated or deleted the original 
cysteine pattern consisting of 4 CXnC motifs, and contained deletions of either 17 or 13 
amino acids (Figure 1.5). The presence of major sequence changes suggested major 
structural rearrangements as well. We solved the tree-dimensional structure of a ligase 
enzyme variant which is described in chapter 3 and compared it to the original scaffold. 
 
 
Figure 1.5-Sequences of starting library and selected artificial RNA ligases [51]. 
Randomized loops are highlighted in blue and Cys residues in orange. Loop 2 was highly conserved among 
all active enzymes isolated suggesting a key role in the new enzyme. Most clones have mutated or lost at 
least two of the original 8 cysteines, and contain major changes such as deletion of 13 and 17 amino acids.  
 
 
1.5.3 Molecular biology applications of the de novo RNA ligase 
All known natural ligases rely on ATP as a cofactor and on a 5' monophosphate to 
perform ligation. These enzymes are used in several molecular biology applications. In 
particular, a common procedure for the analysis of RNA transcripts, involves ligation of 
known sequences (adaptors) at both RNA termini to enable reverse transcription and then 
PCR amplification. The resulting DNA is then characterized by several methods such as 
sequencing or microarray.  
Some classes of RNA, including prokaryotic messenger RNA or secondary short 
interfering RNAs (siRNAs) in C. elegans, are characterized by their triphosphate group at 
the 5' end. Since existing RNA ligases require a monophosphate, the 5'-PPP must be 
dephosphorylated prior to ligation. This additional step complicates sample preparation 
and data analysis [101].  
In 2013, the artificial RNA ligase we characterized was shown to have broad 
substrate specificity and to ligate adaptors to the 5'-PPP end of two siRNAs sequences 
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[101]. These findings demonstrated that the enzyme was potentially suitable for the 
isolation and characterization of any 5'-PPP group, and showed the ability of in vitro 
directed evolution methods to generate useful biocatalysts. 
1.6 Selection of functional proteins from random libraries with mRNA display 
It has been hypothesized that the earliest functional proteins arose from random 
sequences. Both theoretical [102] and experimental work [103] has been conducted to 
verify the plausibility of this hypothesis. For example, in 2009 [102] the structures of 
18465 random protein sequences generated in silico and extracted from an initial pool of 
2x104 proteins, were predicted using the Rosetta software. It was found that these proteins 
possessed well folded secondary and tertiary structures comparable to those of natural 
proteins, and not significantly different biophysical properties. Previous experimental 
work [103] suggested that, given a pool of 109 random 50 amino acids peptides displayed 
on phage, 20% are properly folded, as assessed by results of a proteolysis resistance assay 
performed on 79 clones picked randomly. Other experimental work [104] showed that 
when inserting completely random sequences into a functional scaffold, variants 
maintaining the initial activity could be found. 
One study [105] addressed experimentally the question of what is the frequency 
of functional proteins in random libraries. In 2001, Keefe and Szostak [105] starting from 
a pool of 6x1012 random proteins of 80 amino acids each, selected for an ATP binding 
protein, using mRNA display. Four different families (A-D) of proteins with sequences 
unrelated to each other and to natural proteins were found. In particular, one of the 
isolated variants had a very high affinity for ATP of (Kd= 100 nM)  
Furthermore, X-ray crystallography studies showed a novel fold characterized by 
three β-strands and two α-helices, which was stabilized by coordination of a zinc atom 
[106]. No other examples of zinc stabilized nucleotide binders were observed in nature. 
Interestingly, zinc was not added during the selection step, but was present during 
translation as a component of the translation lysate. This suggested that metal 
coordination is a strategy to readily generate folded structure of polypeptides, while 
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decreasing the amount of sequence information needed to generate folded functional 
proteins.  
These results indicate that random libraries are a source of folded and functional 
proteins. However, the idea that catalytic activity is too complex to arise from completely 
random libraries [107] limited the attempts to select enzymes from this type of libraries. 
Only few studies are available which involved prescreening for solubility [108,109], or 
the use of random binary patterned libraries to enrich for secondary structures [110]. 
However, while most known three-dimensional structures of modern enzymes fall in the 
category of well-folded structures [111], a view biased by the structure of proteins that 
can be crystallized, the possibility that primordial enzymes lacked this level of 
complexity cannot be discounted. In order to enable a low level of activity, a functional 
binding site, with more rigid requirements for binding the substrate and catalysis, are 
needed while the rest of the sequence could be under lower selection pressure, increasing 
the chances of selecting for catalytic activity from unbiased library.  
This reasoning, in combination with evidence for functionality in libraries of 
random sequences, prompted us to start the selection of an RNA ligase from a random 
library [37] that was previously used as input for the selection of the ATP binder 
described above [105]. 
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Chapter 2 : Thermostable artificial enzyme isolated by in vitro selection 
This chapter is a reprint of the article: Morelli, A., Haugner III, J. C., and Seelig, 
B. (2014) Thermostable artificial enzyme isolated by in vitro selection. PLOS ONE. No 
permission from the editor is required to reuse the article as long as the original article is 
cited. I purified the artificial ligases by size exclusion chromatography and characterized 
thermal stability and secondary structure by circular dichroism. Haugner expressed and 
purified ligases by Ni-NTA chromatography and performed activity assays. Dr. Seelig 
designed and performed the selection of the heat stable ligases. 
2.1 Summary 
Artificial enzymes hold the potential to catalyze valuable reactions not observed 
in nature. One approach to build artificial enzymes introduces mutations into an existing 
protein scaffold to enable a new catalytic activity. This process commonly results in a 
simultaneous reduction of protein stability as an undesired side effect. While protein 
stability can be increased through techniques like directed evolution, care needs to be 
taken that added stability, conversely, does not sacrifice the desired activity of the 
enzyme. Ideally, enzymatic activity and protein stability are engineered simultaneously to 
ensure that stable enzymes with the desired catalytic properties are isolated. Here, we 
present the use of the in vitro selection technique mRNA display to isolate enzymes with 
improved stability and activity in a single step. Starting with a library of artificial RNA 
ligase enzymes that were previously isolated at ambient temperature and are therefore 
mostly mesophilic, we selected for thermostable active enzyme variants by performing 
the selection step at 65°C. The most efficient enzyme, ligase 10C, is not only active at 
65°C, but is also an order of magnitude more active at room temperature compared to 
related enzymes previously isolated at ambient temperature. Concurrently, the melting 
temperature of ligase 10C increased by 35 degrees compared to these related enzymes. 
While low stability and solubility of the previously selected enzymes prevented a 
structural characterization, the improved properties of the heat-stable ligase 10C finally 
allowed us to solve the three-dimensional structure by NMR. This artificial enzyme 
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adopted an entirely novel fold that has not been seen in nature, which was published 
elsewhere. These results highlight the versatility of the in vitro selection technique 
mRNA display as a powerful method for the isolation of thermostable novel enzymes. 
2.2 Introduction 
 Protein stability is often a limiting factor for the application, engineering and 
structural studies of proteins. Low protein stability can result in aggregation, 
susceptibility to protease degradation and poor yields in the expression of soluble protein, 
thereby complicating the study and use of these proteins. For commercial applications, 
proteins commonly need to be particularly stable to increase their tolerance to process 
conditions like high temperatures or organic solvents [34]. Furthermore, proteins with 
low stability are less tolerant to mutations thereby limiting further engineering because 
even slightly destabilizing mutations can lead to unfolding. This can create situations 
where mutations that would improve enzyme activity in a protein engineering project 
appear ineffective because the enzyme was not stable enough to remain folded [112]. 
Conversely, improved thermal stability correlates with mutational robustness and 
evolvability [113]. 
 Methods to increase the thermodynamic stability of proteins include rational 
design, consensus-based design, directed evolution, and commonly some combination of 
these approaches [114]. Rational design introduces mutations predicted to enable 
additional stabilizing interactions [115]. However, this approach requires extensive 
structural knowledge, substantial computing power and is technically challenging, which 
still limits the accessibility of this method. Consensus based-design utilizes phylogenetic 
information to determine which amino acids are preferred at certain positions [115]. This 
method can also be used to reconstruct thermostable ancestral proteins or, be combined 
with structural knowledge, which likely further improves the prediction of stabilizing 
mutations. However, these approaches are dependent on the quality of the constructed 
phylogenetic tree, which is non-trivial to accurately assemble. Directed evolution is a 
combinatorial approach that introduces mutations at random and then screens for desired 
properties such as improved activity or stability [116-118]. High throughput screens are 
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often performed in vivo, utilizing colorimetric [119] or fluorescent [120] reporters to 
measure levels of soluble expression as readout for stability or in vitro using protease 
resistance and phage display [121,122]. Protein variants are also commonly assayed 
directly for thermostability and activity as purified proteins, but these methods have a 
relatively low throughput [114,123]. As mutations are introduced randomly, the chance 
of success increases with the number of mutants sampled. This favors high throughput 
methods which can sample millions to trillions of mutants [124,125]. Individual methods 
aimed to generate more stable protein variants can also be combined for best results as 
was demonstrated by consensus design that used the sequence output of a library 
selection [126]. 
 We previously reported the in vitro selection of de novo RNA ligase enzymes that 
catalyze a reaction not observed in nature [51]. These artificial enzymes ligate RNA with 
a 5'-triphosphate to the 3'-hydroxyl of second RNA forming a native 5'-3' linkage and 
releasing pyrophosphate. These artificial ligases are zinc dependent metalloenzymes of 
about 10 kDa. Several enzymes resulting from this in vitro selection experiment were 
analyzed in more detail. All examined enzymes were soluble when expressed as fusion 
proteins with maltose-binding protein (MBP), but most enzymes were poorly soluble 
when expressed on their own. NMR HSQC spectroscopy of the most soluble clone, ligase 
#6, revealed that a significant portion of the protein was well-folded, yet the overall 
resolution of the data was insufficient to solve the three-dimensional structure [51]. To 
overcome this issue, we again utilized in vitro selection. We modified the conditions of 
our original procedure and continued the selection to isolate ligase variants with 
improved stability in order to facilitate structural and mechanistic studies of these 
artificial enzymes.  
Here, we describe in detail the in vitro selection of RNA ligases with increased 
stability. For this directed evolution experiment we utilized the mRNA display 
technology, an in vitro display method, which covalently links each protein to its 
encoding mRNA [69,70]. Using this technology, up to 1013 unique proteins can be 
sampled in a single experiment, which is orders of magnitude more than most other 
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selection strategies [124]. To isolate enzymes with increased thermodynamic stability, we 
modified parts of the selection procedure and performed the ligation step at 65°C. For the 
selection reported here, we used the output library from our previous selection at room 
temperature [51] as starting material. We hypothesized that enzymes, which are active at 
elevated temperature, will have a more stable protein fold that in turn will facilitate 
structural characterization. We also hoped that the increased structural stability would 
correspond to increased solubility and expression in vivo. After several rounds of 
selection, representative ligase clones were sequenced and tested for soluble expression 
in E. coli. The soluble and most active ligase 10C was characterized further and its 
activity and stability were compared to two closely related sequences from the previous 
selection at room temperature. The experiments revealed that ligase 10C is both more 
stable and more active than either of these ligases. The structure of ligase 10C will be 
described in chapter 3, and an application for this enzyme was previously published 
[127,128]. This is the first report of an mRNA display selection at high temperature. 
These results demonstrate the efficacy of mRNA display for isolating thermostable 
enzymes as stability and activity are selected simultaneously in a high throughput 
experiment.  
2.3 Results 
2.3.1 Setup of selection procedure 
 Sequence analysis of the artificial RNA ligase enzymes that resulted from the 
final round of the previous in vitro selection performed at 23°C [51] revealed substantial 
sequence diversity. The DNA encoding those diverse ligases was used as the starting 
library for the selection at 65°C described in this paper without introducing further 
sequence diversity. The RNA ligation reaction catalyzed by the previously selected 
enzymes is dependent on a complementary splint oligonucleotide that base-pairs to the 
two substrate RNAs [51] (Figure 2.1). During the selection at 23°C, this splint base-
paired to eight nucleotides of each substrate (Figure 2.1B). In order to ensure stable base-
pairing during a splinted ligation at elevated temperatures, a longer splint was chosen to 
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extend the region complementary to each substrate to twenty nucleotides (Figure 2.1C). 
The 40-nucleotide-long splint resulted in a melting temperature of 76°C and 69°C with 
the PPP-substrate and the HO-substrate, respectively (Figure S2.1).  
 
 
Figure 2.1-In vitro selection of artificial ligase enzymes with increased stability. 
(A) Schematic of the isolation of ligase enzymes. The DNA library encodes the library of proteins that 
resulted from the original selection of ligase enzymes at 23°C [51,52]. The DNA is transcribed into RNA, 
modified with puromycin at the 3'-end and translated in vitro yielding a library of mRNA-displayed 
proteins [52]. Reverse transcription with a primer containing one RNA substrate shown in red results in a 
complex of protein, mRNA, cDNA and substrate. This complex is incubated at 65°C with the second RNA 
substrate (red) and the complementary splint as highlighted in the orange box. The cDNA of ligases active 
at this temperature is immobilized on streptavidin beads and amplified for subsequent rounds of selection, 
or identified by cloning and sequencing. (B) Detailed view of ligation reaction substrates in complex with 
the mRNA-displayed protein. The two strands of RNA in red, the 59-triphosphate RNA (PPP-substrate) 
and 39-hydroxyl RNA (HO-substrate), are joined in a template-dependent ligation reaction. The PPP-
substrate is part of the reverse transcription primer. The photocleavable site (PC) is used to release the 
cDNA that encodes active enzymes from streptavidin immobilization by irradiation at 365 nm. The splint 
acts as template of the ligation and base pairs with 8 nucleotides of each RNA substrate during the 
previously published selection at 23°C [51,52], and with (C) 20 nucleotides of each substrate during the 
current selection at 65°C. HEG4 represents the linker of four hexaethylene glycol units (red wavy line). 
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 To enable the selection of active enzymes, the PPP-substrate was linked to the 
mRNA-displayed proteins via the reverse transcription (RT) primer that initiates the 
cDNA synthesis (Figure 2.1A). This linkage resulted in a high local concentration of 
substrate in the vicinity of each protein. In order to reduce this local concentration and 
thereby favor the selection of enzymes with an increased substrate affinity, we 
lengthened the RT primer by an additional eighteen non-complementary nucleotides and 
four flexible hexaethylene glycol linker units (HEG4, Figure 2.1C). The hexaethylene 
glycol linker simply acted as a long unstructured tether to increase the average distance 
between protein and substrate. The use of the longer RT primer in combination with the 
splint of 40 nucleotides (nt) in length (Figure 2.1C) resulted in a ligase activity of about 
50% compared to a ligation using the shorter RT primer and the 16 nt splint (Figure 
2.1B).  
 We then evaluated the ligase activity of the starting library at increasing 
temperatures in order to determine a temperature at which the majority of the library 
members are inactive. Using the 40 nt splint and the HEG4-RT primer, at 65°C no 
ligation was detectable (< 10%), whereas at 60°C the ligation activity was about half of 
the activity measured at 23°C. Therefore, we decided to carry out the selection for higher 
stability at 65°C. 
 During the previous selection for ligases, 57% of the isolated enzymes had 
acquired a second FLAG binding sequence (DYKXXD) in addition to the FLAG binding 
sequence that was part of the N-terminal constant region. This was likely a result of a 
selection bias caused by two FLAG affinity purification steps per round of selection. In 
order to counteract this FLAG purification bias, we changed the selection protocol to 
using the E-tag affinity purification instead. Therefore, we replaced the FLAG tag coding 
sequence in the N-terminal constant region of the library with an E-tag sequence by PCR. 
The ligation activity was unaffected by the change of tags.  
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2.3.2 In vitro selection at 65°C 
 To enrich for RNA ligase enzyme with increased thermostability, we performed a 
total of six rounds of selection and amplification (Figure 2.1A). After reverse 
transcription, the mRNA-displayed proteins were incubated with the HO-substrate-65 and 
the RNA splint for 60 min and/or 5 min. The percentage of cDNA that was immobilized 
on streptavidin beads after each round of selection is shown in Figure 2.2. In the case of 
the 60 minute incubation, the percentage of immobilized cDNA increased steadily over 
the course of the selection, from 0.61% after round 1 to 6.6% after round 6. In order to 
increase the selection pressure by favoring enzymes with faster ligation rates, in round 4, 
we incubated a second aliquot of the mRNA-displayed proteins for only 5 min yielding 
0.66% immobilized cDNA. This cDNA was used as input for following round, but no 
increase in the amount of immobilized cDNA after 5 min incubation was observed in 
round 5 (amount decreased to 0.41%). Therefore, we performed the sixth and final round 
of selection, again with 60 min incubation. The resulting DNA was cloned and sequenced 
for further analysis. 
 
 
Figure 2.2-Progress of selection for ligases at 65°C. 
The fraction of 32P-labelled cDNA that bound to streptavidin agarose after each round of selection is 
shown. The reaction time was either 60 min or 5 min as indicated by black or gray bars, respectively.  
 
2.3.3 Sequence analysis and expression of selected ligases 
 The sequence alignment of 32 clones from the sixth round of selection at 65°C 
revealed two protein families (Figure S2.2). One representative clone from each family 
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was cloned and expressed in E. coli to examine soluble expression (Figure S2.3). While 
both clones expressed well, ligase 10C was highly soluble whereas ligase 10H was 
largely insoluble. Furthermore, native Ni-NTA affinity purification of ligase 10H yielded 
no soluble protein (data not shown) and, therefore, ligase 10H was not characterized 
further.  
 The sequence of ligase 10C shares similarities to ligases #6 and #7 from the 
original selection with #7 being more similar (Figure 2.3). All three ligases are almost 
identical in sequence in the formerly randomized region 2, and all three share the deletion 
of 17 amino acids following region 1. Ligases 10C and #7 also share the sequence in 
region 1, but 10C contains a second deletion of 13 amino acids near the C-terminus. This 
C-terminal deletion is also found in other clones from the selection at 23°C [51], but these 
proteins were poorly soluble when expressed without an maltose-binding protein fusion 
and therefore unsuited for a direct comparison. 
 
 
Figure 2.3-Sequence alignment of the library used as input for original ligase selection [129] with 
ligases #6, #7 [51] and 10C that were selected at 23°C and at 65°C, respectively [130,131]. 
The amino acids in regions 1 and 2 of the original library were randomized prior to the selection at 23°C 
and are shown as “x”. Dashes symbolize amino acids that are identical to the starting library. A period 
highlighted in gray represents a deletion. The underlined N-terminal amino acids of the library and ligase 
10C represent a Flag epitope tag and an E epitope tag, respectively.  
 
2.3.4 Activity of ligase enzymes 
 To compare the enzymatic activity of ligase 10C to ligases #6 and #7, we assayed 
the three enzymes at 23°C and 65°C (Figure 2.4). Ligase 10C was the only enzyme active 
at 65°C. In comparison, ligases #6 and #7 were active at room temperature as expected, 
but had no measurable activity at 65°C. In addition to its activity at 65°C, ligase 10C was 
also active at room temperature. To compare the activity of the three enzymes more 
accurately, we measured the kobs for each ligase at 23°C. At a subsaturating substrate 
concentration of 10 μM, ligase 10C had a kobs of 0.165 ± 0.015 h-1 while ligases #6 and 
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#7 had kobs of 0.0174 ± 0.0066 h-1 and kobs of 0.0207 ± 0.0045 h-1, respectively (Table 
S2.1). This represents an 8 to 10-fold increased activity of ligase 10C compared to ligases 
#6 and #7 even at 23°C. While the main goal of the selection was to isolate an enzyme 
with greater thermostability, as an added benefit, the most stable enzyme also featured an 
improved catalytic rate at room temperature.  
 
 
Figure 2.4-Activity of ligase enzymes assayed at different temperatures. 
Ligases #6 and #7 had been selected previously at 23°C [51,52] and ligase 10C was selected at 65°C. In this 
assay, the 32P-labeled PPP-substrate-65, HO-substrate-65 and 40 nt splint were incubated with the 
individual enzymes for 16 h and activity monitored by gel-shift. 
 
2.3.5 Characterization of thermal stability by circular dichroism (CD) 
 In order to assess if the unique enzymatic activity of ligase 10C at 65ºC was 
correlated to increased structural stability, we measured thermal denaturation curves of 
all three ligases by circular dichroism. In preparation of the thermal unfolding 
experiment, we measured the CD spectra of the three enzymes (Figure S2.4). All three 
spectra exhibited two minima of negative ellipticity at 205 nm and between 220 and 225 
nm, respectively. While those minima suggested α-helical secondary structural content 
[132], the 205 nm minimum was substantially more negative than the second minimum, 
which differs from purely alpha helical proteins that have similar absolute values for both 
minima. Nevertheless, we used the strong negative ellipticity of all three ligases at 222 
nm to monitor thermal unfolding of the proteins over a temperature range from 5 to 91 
ºC. We found all three enzymes to give the characteristic single sigmoidal transition 
 36 
 
corresponding to a two-state unfolding reaction (Figure 2.5). As determined from the 
curves, the enzymes showed very different melting temperatures. Ligase 10C had the 
highest melting temperature (Tm = 72ºC), which was 35 degrees higher than the Tm of 
ligase #6 (37ºC), and 24 degrees higher than the Tm of ligase #7 (48ºC). The high melting 
temperature of 72ºC for ligase 10C was in agreement with its retained enzymatic activity 
at 65ºC as the enzyme has not undergone unfolding yet. In contrast, ligases #6 and #7 
were fully denatured at 65ºC, and, therefore, their complete lack of enzymatic activity at 
65ºC could be explained by their unfolding. 
 
 
Figure 2.5-Thermal unfolding curves of ligases #6, #7 and 10C. 
Thermal unfolding was monitored by circular dichroism at 222 nm. For each measurement 10 
accumulations were acquired. 
2.4 Discussion 
 We isolated a thermostable artificial RNA ligase enzyme by in vitro selection at 
65°C of a library of artificial ligases that were originally generated at 23°C. The isolated 
ligase 10C was more thermostable and more active than the two most closely sequence-
related ligases #6 and #7 identified during the selection at 23°C. Ligase 10C has a melting 
temperature (TM) of 72°C corresponding to a stability increase of 24 degrees compare to 
#7, and 35 degrees compared to ligase #6. Previously reported TM improvements through 
protein engineering are commonly between 2 to 15 degrees [115]. The TM increase by 35 
degrees reported here favorably compares with those rare examples of ‘record-setting 
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stabilizations’ [114,133-135]. While the ligases #6 and #7 have no measurable enzymatic 
activity at 65°C, ligase 10C ligates RNA at 65°C with an activity that is similar to its 
activity at 23°C. Furthermore, the activity of ligase 10C at 23°C is about an order of 
magnitude higher than the activity of the ligases #6 and #7 at the same temperature.  
 The increased thermostability of ligase 10C is likely due to improved 
intermolecular contacts within the protein compared to the mesophilic ligases #6 and #7. 
In contrast to these enzymes isolated at 23°C, the properties of ligase variant 10C were 
suitable to solve its three-dimensional solution structure by NMR [20]. The structure 
featured a small, well-folded core coordinated by two Zn2+-ions. In addition, the folding 
core also contained a highly dynamic internal loop and was framed by unstructured 
termini. In order to discuss a potential correlation between differences in primary 
sequence and altered thermal stability, we mapped sequence differences between ligase 
#7 and 10C onto the structure of 10C (Figure 2.6). We chose ligase #7 for comparison 
because despite the high sequence similarity it showed a large difference in 
thermostability. All differences between these two ligases are found in or near the 
structured region responsible for zinc coordination. We previously demonstrated by 
NMR that residues Ile68 and His69 near the C-terminus of ligase 10C made long range 
NOE contacts with several residues at the N-terminus (Lys17, His18, Ala27 and 
Glu28)[127]. Notably, His18 is one of the zinc coordinating residues in 10C and mutating 
this position to Ala resulted in a drastically reduced solubility of the protein [127]. In 
addition, ligase #7 contained an additional 13 amino acids located between the residues 
corresponding to Ile68 and His69 in ligase 10C, which likely moved His69 and prevented 
its contacts with Lys17, His18 at the N- terminus. Presumably, all these mutations could 
compromise the intramolecular interactions in these positions reported for ligase 10C and 
decrease the stability of ligase #7 at high temperature. Ligase 10C also differed from 
ligase #7 in two additional positions (Ser54 and Asp65) which may further influence 
protein stability. A direct comparison of the overall flexibility of ligase 10C and the two 
mesophilic ligases would require solving also the structures of ligases #6 and #7 by 
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NMR. This would be beyond the scope of our characterization, and preliminary 
experiments suggested that ligase #6 is not amenable to detailed NMR studies. 
 
 
Figure 2.6-Sequence differences between ligase #7 and ligase 10C mapped onto the NMR structure of 
ligase 10C [127].  
Mutations are shown in red. Residues potentially perturbed by the mutations are labeled in blue and long 
range NOEs are shown as dashed black lines. The two coordinated zinc ions as depicted as orange spheres 
and the residue numbers refer to ligase 10C. The unstructured termini of ligase 10C were omitted for 
clarity. 
  
The in vitro selection at 65°C not only yielded the family A of related sequences 
that included ligase 10C (Figure S2.2), but also a second family B represented by ligase 
10H which could not be expressed solubly in E. coli. During the original selection at 
23°C, we noted that of the seven ligases characterized, only #6 and #7 were soluble 
without being expressed as a MBP fusion. While ligase 10C is closely related to #6 and 
#7, ligase 10H is most similar to ligase #1 which also did not express solubly. Isolating 
proteins like ligase 10H and ligase #1 is not surprising because mRNA display uses a 
eukaryotic in vitro translation system and therefore soluble expression in E. coli was 
never directly selected for. Additionally, the covalently linked RNA increases protein 
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solubility which can also contribute to this result. In general, this solubilizing effect is a 
favorable feature of mRNA display because it allows identifying proteins that might be 
lost during other selection techniques due to poor solubility. It is possible that ligase 10H 
could be solubilized through MBP fusion like ligase #1, but such a modification would 
have complicated subsequent structural studies. 
 Considering the high melting temperature of 72°C for ligase 10C, it is particularly 
surprising to discover the lack of secondary structural motifs like α-helices or β-strands 
combined with highly dynamic regions [127]. The structure of this artificial enzyme does 
appear to match with any known protein folds. While it is increasingly appreciated that 
catalytic activity of enzymes can require conformational flexibility [136-138], thermal 
stability is usually associated with tight packing and rigidity. Generally, thermophilic 
enzymes possess well packed hydrophobic cores [139], few exposed surface loops [140] 
and additional stabilizing interactions such as salt bridges [141] and a high number of 
hydrogen bonds [142]. These features lead to an increased rigidity that, while favoring 
stability at higher temperature, often appears to decrease activity at lower temperature. 
This observation has been interpreted to mean that stability, dynamics and catalysis are a 
tradeoff, but this common notion has recently been called into question [143]. The 
structure of the ligase 10C [127] combines a high flexibility and the absence of a packed 
hydrophobic core with thermostability, and is equally active at 65°C and at ambient 
temperature. The structure of this de novo enzyme challenges the common view of how 
enzymes are supposed to look - a view that is biased by proteins amenable to 
crystallization.  
The high degree of disorder and flexibility present in 10C might be a feature that 
favors its evolvability. For example, the presence of disordered regions and a loosely 
packed structure found in viral proteins, structural characteristics similar to those found 
in 10C, may allow for increased evolvability because each mutation, due to a lower 
amino acid interconnectivity, would lead to a slower loss in stability, compared to the 
more packed structures of thermophilic enzymes [144]. Similarly, ligase 10C might also 
be highly evolvable because of its flexible structure and disordered regions. Yet, this 
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artificial enzyme was generated de novo and, unlike biological proteins, has not been 
shaped by billions of years of evolution. As its structure and function has just come into 
existence, ligase 10C could be considered a model protein for primordial enzymes. For 
these reasons, properties of this enzyme like its evolutionary potential will be interesting 
to study, however comparisons to natural proteins might be challenging. 
 The starting library for this selection at elevated temperature was a mixture of 
protein variants that was final the output of the previously described selection for 
artificial ligases at 23°C [51]. No further genetic diversity had been introduced. 
Sequencing of the starting library showed a diverse mixture of unrelated sequences and 
sequence families. Ligase 10C had not been observed during the sequencing of 49 
individual clones and was only sufficiently enriched and detected after the subsequent 
selection at 65°C. It is conceivable that future mutagenesis and directed evolution of 
ligase 10C using the same selection strategy will further improve thermal stability and 
activity. These studies will help us understand the evolutionary potential of this artificial 
enzyme and also yield improved catalysts for a variety of applications [128]. 
2.5 Conclusions 
 The discovery of this thermostable enzyme and its unusual structure emphasizes 
the value of directed evolution approaches that do not require a detailed understanding of 
protein structure-function relationships, but instead randomly sample sequence space for 
functional proteins. In contrast, it would have been impossible to construct this particular 
artificial enzyme by rational design despite recent advances in rational protein 
engineering. In the current project, we employed the in vitro selection technique mRNA 
display [69,70]. This method uses product formation as the sole selection criterion and is 
independent of the mechanism of the catalyzed reaction. The technique has several 
advantages over other selection strategies [35]. The mRNA display technology enables to 
search through large libraries of up to 1013 protein variants. This feature is beneficial 
because the chance of finding a desired activity increases with the number of variants 
interrogated. Furthermore, the in vitro format of this method allows selecting for activity 
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under a wide range of conditions, which is similar to the common approach of screening 
much smaller libraries of purified proteins, but in contrast to in vivo selection strategies 
where maintenance of cell viability limits the experimental possibilities. Previous reports 
on mRNA display include the improvement of folding and stability of proteins by 
selecting for resistance to protease degradation [35], or by selecting in the presence of 
increasing amounts of the denaturant guanidine hydrochloride [145,146]. Interestingly, in 
parallel to our successful selection for RNA ligases at elevated temperature, we also 
attempted a similar selection in presence of guanidine hydrochloride, but no enrichment 
was observed even after six rounds (data not shown). Nevertheless, to our knowledge the 
work presented here is the first description of an mRNA display selection at elevated 
temperatures yielding thermostable proteins. The in vitro format of mRNA display should 
facilitate other selections at a variety of pH, temperatures, ionic strength, or in the 
presence of co-solvents, inhibitors or other chemicals. Such experiments will help to 
study the coevolution of protein stability and activity, and also has the potential to 
produce proteins that are more stable in industrial or biomedical applications.  
2.6 Materials and methods 
2.6.1 Preparation of oligonucleotides 
 32P-labeled PPP-substrate-23 used in original selection at 23°C (5'-PPP–
GGAGACUCUUU) and PPP-substrate-65 for selection at 65°C (5'-PPP–
GGAGAUUCACUAGCUGGUUU) were prepared through T7 transcription as reported 
previously [51,52]. The HO-substrate-23 (5'–CUAACGUUCGC), HO-substrate-65 (5'-
UCACACUGUCUAACGUUCGC) and HO-substrate-65-Bio (5'-(PC)-
UCACACUGUCUAACGUUCGC, (PC) represents PC biotin phosphoramidite from 
Glen Research, Sterling VA) were purchased from Dharmacon (Lafayette, CO) and 
prepared according to the manufacturer’s protocol. The DNA splint (5'–
GAGTCTCCGCGAACGT) complementary to the substrates-23 and RNA splint (5'- 
AAACCAGCUAGUGAAUCUCCGCGAACGUUAGACAGUGUGA) complementary 
to the substrates-65 were purchased from Integrated DNA Technologies (Coralville, IA). 
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The reverse transcription primer (HEG4-RT) was produced by ligating the PPP-substrate-
65 to BS75P-HEG4 in the presence of BS76 as template using T4 DNA ligase [147] and 
purified by denaturing PAGE. All oligonucleotides were dissolved in ultra-pure water 
and concentrations determined by UV absorbance. 
 
2.6.2 Selection of RNA ligases at 65°C 
 The mRNA display selection was performed as previously published [51], with 
the following exceptions. Primers BS99 and BS24RXR2 were used to amplify the DNA 
by PCR. Primer BS99 replaces the N-terminal FLAG affinity tag that was used in the 
previous selection at room temperature [51] with the E-tag. Accordingly, both FLAG 
affinity purification steps in the previous protocol were substituted by E-tag affinity 
purifications. For the first E-tag purification, the mRNA-displayed proteins eluted from 
the oligo(dT)cellulose were mixed with binding buffer (same as Flag binding buffer [51]) 
and then incubated for 30 min at 4°C with rotation with 25 µL Anti-E affinity gel (from 
Anti E-tag affinity column, GE healthcare Biosciences; prewashed with E clean buffer 
(100 mM glycine, pH 3.0, 0.05% Tween-20) and binding buffer). The Anti-E tag affinity 
gel was then washed with binding buffer and eluted with binding buffer containing two 
equivalents of E-peptide (Bachem, Osteocalcin (7-19, human); one equivalent of E-
peptide saturates the antigen sites of the antibody resin) for 3 min at 4°C. The second E-
tag purification was performed in a similar fashion using 50 µL Anti-E affinity gel and 6 
equivalents of E-peptide to elute. The elution from the second E-tag affinity purification 
was incubated with the HO-substrate-65-Bio and the RNA splint in presence of 2 mM 
MgCl2 and 100 µM ZnCl2 for 1 hour at 65°C in selection rounds 1, 2, 3 and 5. In round 4, 
the sample was divided into two aliquots, one of which was incubated for 1 h, and the 
other aliquot was incubated for 5 min. The reaction was quenched and purified on 
streptavidin beads as described previously [51], and the photocleaved DNA was 
amplified by PCR and used as input for the following round. For the starting material in 
round 5, the photocleaved DNA from round 4 was used that resulted from the 5 min 
incubation.  
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2.6.3 Expression and purification of RNA ligases 
 RNA ligases were expressed and purified as previously described [127]. 
 
2.6.4 Screening for ligase activity by gel-shift assay 
 5 μM 32P-labeled PPP-substrate-65, 6 μM RNA splint, 7 μM HO-substrate-65, 20 
mM HEPES pH 7.5, 100 mM NaCl, 100 μM ZnCl2 and 1.7 μM enzyme (purified by Ni-
NTA affinity chromatography [127]) were combined and incubated for 16 hours at 23°C 
and 65°C. Reactions were stopped by the addition of EDTA to a final concentration of 10 
mM. Immediately following, the RNA was denatured for 40 min at 65°C in 7.5% 
formaldehyde, 58% formamide and 11.6 mM MOPS pH 7.0. Samples were separated by 
20% denaturing PAGE gel containing 2% formaldehyde. The gel was analyzed using GE 
Healthcare (Amersham Bioscience) Phosphorimager and ImageQuant software 
(Amersham Bioscience). The amount of radiation in both the substrate and product bands 
was measured and % ligated was determined by dividing the intensity of the product band 
by the sum of the product and substrate bands. 
 
2.6.5 Determination of observed rate constants (kobs) 
 5 μM enzyme (purified by Ni-NTA affinity and size exclusion chromatography 
[127]) was incubated with 10 μM 32P-labeled PPP-substrate-23, 15 μM DNA splint, 20 
μM HO-substrate-23 and ligation was monitored up to 2 hours at 23°C. Reactions were 
quenched with two volumes of 20 mM EDTA in 8 M urea after 0, 15, 30, 60 and 120 
minutes, heated to 95°C for 4 min and separated by 20% denaturing PAGE gel. The gel 
was analyzed using GE Healthcare Phosphorimager and ImageQuant software 
(Amersham Bioscience). The rate constant (kobs) was determined by taking the slope of 
the linear fit of % ligated over time and correcting for enzyme concentration by 
multiplying by the ratio of PPP-substrate to enzyme (10 uM : 5 uM or 2) resulting in a 
value with the unit per hour (h-1).  The reported values are an average of 3 independent 
replicates ± the standard deviation.  Total conversion was < 10% for all cases. 
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2.6.6 Circular dichroism and thermal denaturation 
 Ligase enzymes (purified by Ni-NTA affinity and size exclusion chromatography 
[127]) were concentrated to 50 μM and dialyzed against CD buffer (150 mM NaCl, 2 
mM HEPES, 0.5 mM 2-mercaptoethanol, 100 μM ZnCl2). Circular dichroism spectra and 
thermal denaturation curves were recorded on a JASCO J-815 spectropolarimeter at 30 
μM or 50 μM protein, respectively. The following parameters were used for both 
measurements: 1.5 nm band width, 2 seconds response time, standard sensitivity, 10 
accumulations. The ellipticity at 222 nm was monitored to determine thermal 
denaturation curves over a temperature range from 5 to 91°C with a ramp rate of 1°C/min 
and a temperature pitch of 2°C. 
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2.7 Supplementary information 
Table S 2.1- Data for determining kobs. 
Replicate Ligase 10C Ligase 6 Ligase 7 
Slope [a] R2 Slope R2 Slope R2 
1 0.0894 h-1 0.973 0.0124 h-1 0.910 0.0128 h-1 0.989 
2 0.0828 h-1 0.982 0.00768 h-1 0.951 0.00984 h-1 0.993 
3 0.0750 h-1 0.981 0.00599 h-1 0.834 0.00840 h-1 0.991 
 [a] Five time-points were used for ligases #6 and #7. Only the first four time-points were used for ligase 
10C as the final point had begun to plateau and would have skewed the analysis. 
Table S 2.2- Sequences of ligases 10C and 10H selected at 65°C; and ligases #6 and #7 selected 
previously at 23°C for comparison. 
Ligase 10C MGAPVPYPDPLEPRGGKHICAICGNNAEDYKHTDMDLTYTDRDYKNCESYHKCSDLCQYCRYQKDLAIHHQHHHGGSMGMSGSGTGY 
Ligase 10H MGAPVPYPDPLEPRGGKHICAICGDILDDDYDYKQTDSREGRQGFFKRTLRKDLTYSCRDYKYRESYHKCSDLCQSCRYQKALAIHHQHHHGGSMGMSGSGTGY 
Ligase #6 MDYKDDDDKDGKHICAICGDTVTNTDYKTPDLTSTCRDYKNRESYHKCSDLCQYCRYQKALAMGTKREAAQEEVGSHHQHHHGGSMGMSGSGTGY 
Ligase #7 MDYKDDDDKGGRHICAICGNNAEDYKHTDMDLTYTDRDYKNCESYHKCQDLCQYCRYQKALAMGIKREAVQEEVGSHHQHHHGGSMGMSGSGTGY 
Table S 2.3- Sequences of oligonucleotides. 
BS75P-HEG4 5'-P-TGTACGATTCGATGACGA-HEG4--TTTTTTTTTTTTTTTCCCAGATCCAGAC
ATTC (“P” represents the 5'-phosphate group, “HEG4” represents four hexaethylene 
glycol units (Spacer18 from Glen Research, Sterling, VA) 
BS76 5'-TCGTCATCGAATCGTACAAAACCAGCTAGTGAATC 
BS99 5'-TCTAATACGACTCACTATAGGGACAATTACTATTTACAATTACAATGGGAG
CACCAGTCCCTTACCCTGATCCGCTGGAACCGCGTGGCGGAAAGCACATCTG
C 
BS24RXR2 5'-TTAATAGCCGGTGCCAGATCCAGACATTCCCATAGAACCGCCATGATGATG 
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Figure S 2.1-Thermal denaturation of substrate and splint oligonucleotides used in the selection and 
activity assays at 65°C.  
The first derivative of the melting curve for the 40 nt splint in the presence of both PPP-substrate-65 and 
HO-substrate-65 RNA oligonucleotides is presented. The concentration of each oligonucleotide was 0.5 
µM in a buffer containing 70 mM KCl, 100 µM ZnCl2, 5 mM 2-mercaptoethanol and 20 mM HEPES at pH 
7.5.  
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Figure S 2.2- Clones identified from round 6 of the in vitro selection at 65°C.  
Two protein families (A, B) were identified and a representative clone from each family was chosen for 
further characterization (10C and 10H, shown in red). 
Figure S 2.3-Protein expression in E. coli of representative ligases selected at 65°C.  
A Coomassie-stained SDS-PAGE gel shows samples of whole cells pre- and post-induction and the 
insoluble and soluble fractions after cell lysis and centrifugation. Red boxes in the lane “Soluble fraction” 
indicate the presence or absence of soluble ligases 10C and 10H, respectively. 
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Figure S 2.4-Circular dichroism spectra of ligases #6, #7 and 10C at 25°C. 
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Chapter 3 : Structure and dynamics of a primordial catalytic fold 
generated by in vitro evolution 
The following is a reprint of the article: Chao, F.-A., Morelli, A., Haugner III, J. 
C., Churchfield, L., Hagmann, L. N., Shi, L., Masterson, L. R., Sarangi, R., Veglia, G., 
and Seelig, B. (2013) Structure and dynamics of a primordial catalytic fold generated by 
in vitro evolution. Nat. Chem. Biol. 9, 81-83. The article is reprinted here with permission 
from Macmillan Publishers Ltd. Chao solved the structure of the ligase by NMR, 
supported by Masterson and Shi. I prepared protein samples for NMR and biochemical 
characterization, and characterized the enzyme by CD and mass spectrometry. 
Churchfield and Haugner characterized mutants by activity assays and CD. Sarangi 
characterized the zinc coordination by EXAFS. 
Hyperlink to original publication: 
http://www.nature.com/nchembio/journal/v9/n2/full/nchembio.1138.html 
3.1 Summary 
Engineering functional protein scaffolds capable of carrying out chemical 
catalysis is a major challenge in enzyme design. Starting from a non-catalytic protein 
scaffold, we recently generated a novel RNA ligase by in vitro directed evolution. This 
artificial enzyme lost its original fold and adopted an entirely novel structure with 
dramatically enhanced conformational dynamics, demonstrating that a primordial fold 
with suitable flexibility is sufficient to carry out enzymatic function. 
3.2 Introduction 
The known structures of naturally occurring proteins can be assigned to an 
apparently finite number of different fold families [148,149]. Starting from an existing 
fold, divergent evolution through a combination of gene duplication and mutations is a 
common path for proteins to acquire new functions while retaining their original fold 
[150,151]. However, the origin of those biological folds remains subject to debate 
[152,153]. Only a few examples have been described in which new function acquisition 
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is accompanied by a simultaneous change in the protein fold. Those examples have 
largely been generated by rational design or involve protein binders [91,105,154-158]. 
Recently, we created artificial RNA ligase enzymes by in vitro evolution [51,52]. 
These enzymes catalyze the joining of a 5'-triphosphorylated RNA to the 3'-hydroxyl 
group of a second RNA, a reaction for which no natural enzyme catalysts have been 
found. We began with a non-catalytic small protein domain consisting of two zinc finger 
motifs from the DNA binding domain of human retinoid-X-receptor (hRXRα) [159] 
(Figure 3.1). Two adjacent loops of this protein were randomized to generate a 
combinatorial library of mutants as input for the selection and evolution process [129]. 
Although zinc fingers are common structural motifs, they are not known to take part in 
catalysis in natural proteins. In contrast, we isolated from the zinc finger library active 
enzymes that exhibit rate accelerations of more than two-million-fold [51]. 
3.3 Results 
Sequence analysis of the artificial enzyme showed that several amino acids 
essential to maintaining zinc finger structure integrity were mutated or deleted, 
suggesting that the original scaffold may have been abandoned during the process of 
mutagenesis and evolution. The original hRXRα scaffold consisted of two loop-helix 
domains, each containing a zinc ion tetrahedrally coordinated by four cysteines [159]. 
However, during evolution of the ligase enzyme, only half of the zinc-coordinating 
cysteines had been conserved. In the starting scaffold, two helices were packed 
perpendicularly to form the globular fold and build the hydrophobic core and an 
additional helix was located at the C-terminus (Figure 3.1b). In the ligase enzyme, seven 
residues of the former DNA recognition helix and ten residues of the C-terminal helix 
were deleted from the original hRXRα scaffold.  
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Figure 3.1-Changes in primary sequence and three-dimensional structure upon directed evolution of 
the hRXRα scaffold to the ligase enzyme 10C.  
(a) Comparison of the primary sequences of hRXRα[159] (residues 132-208) and the artificially evolved 
ligase (residues 17-68). The two zinc finger regions are highlighted with purple and green brackets. The red 
letters denote residues that are not conserved between the two sequences. (b) Three-dimensional structure 
of hRXRα[159] and NMR ensemble of ligase 10C (for clarity, flexible termini are not shown). Although 
both proteins contain two zinc fingers, the overall structures are substantially different. Only two zinc-
coordinating cysteines of each zinc finger in hRXRα are still coordinating zinc in ligase 10C (highlighted in 
yellow; also shown in a) whereas all other ligands differ in the two structures. Zinc-coordinating residues 
are labeled and shown in blue. In contrast to that in hRXRα, zinc finger Zn-II in ligase 10C comprises 
residues of both N- and C-terminal sequences, imposing a cyclic structure to the enzyme. Notably, the new 
ligase lost both helical domains of hRXRα (gray), replacing the recognition helix with a long unstructured 
loop (gray). 
 
NMR structural analyses of the ligase 10C, chosen for its superior solubility and 
thermostability, revealed that the evolved ligase lost the original zinc finger scaffold, 
adopting an entirely novel structure (Figure 3.1b). This new 3D structure still contained 
two zinc sites that constitute the folding core of the protein, however, the two Zn2+ ions 
were coordinated by several new ligands with a different register. The deletion of two N-
terminal cysteines during directed evolution resulted in the concomitant rearrangement of 
the local geometry of the zinc-binding loop. Additionally, the short stretch of anti-parallel 
β-sheet within the first zinc finger (Zn-I) was also deleted. The C-terminal loop-helix 
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domains and the recognition helix of hRXRα responsible for binding to the DNA groove 
[160] were lost completely; the latter was replaced by an unstructured loop of twenty 
amino acids connecting the two new zinc fingers. The zinc fingers made up the most 
structured region, as demonstrated by the presence of short- and long-range nuclear 
Overhauser Effect (NOE) contacts. Moreover, several long-range NOEs indicated that the 
two metal-binding loops are in close proximity, while most of the protein presented only 
short range NOE contacts (Figure S3.1 and Table S3.1). The conformational ensemble 
resulting from simulated annealing calculations showed two well-defined regions 
(residues 17-35 and 49-69) with root-mean-square-deviation from the average of less 
than 1 Å, whereas the large loop encompassing residues 36-48 was completely 
unstructured (RMSD greater than 6 Å). The three-dimensional structure of the enzyme 
was compounded by residual dipolar coupling measurements, which also helped to better 
define the local geometry around the zinc binding sites (Figures S3.2 and S3.3).  
The two metal centers were responsible for the overall fold of the ligase. In the 
absence of Zn2+, the NMR fingerprint spectrum of the enzyme displayed broad and 
mostly unresolved resonances, typical of a molten globule. Titration of Zn2+ to the metal-
free protein first saturated the C-terminal Zn2+ binding site (Zn-II) and induced a 
substantial structural rearrangement with sharper and more dispersed resonances (Figures 
S3.4 and S3.5). The transition between the unfolded and folded states of the ligase 
involved multiple intermediate species. For selected resonances, we could discern the 
presence of two distinct states in slow exchange in the NMR time scale. Complete 
saturation with Zn2+ funneled the enzyme into a more defined structure, with the 
complete resolution of fingerprint resonances showing only one population of peaks. 
Elemental analysis by inductively coupled plasma mass spectrometry revealed 2.74 ± 
0.01 equivalents (± s.d.) of bound zinc per ligase molecule. We were able to fit the 
thermocalorimetry data using models with two or more Zn2+ binding sites, however, the 
fit does not improve significantly with n>2 (Figure S3.6 and Table S3.2). Assigning two 
sites in accordance with the NMR titration data leads to one binding site Zn-II with 
higher affinity (Kd ~ 3μM), and a second binding site Zn-I with lower affinity for Zn2+ 
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(Kd ~ 93 μM). These values were further supported by the zinc concentration dependence 
of the enzyme activity, showing a steep drop in activity at concentrations below 100 µM 
Zn2+ (Figure S3.7). Notably, the ligase affinity for Zn2+ was substantially lower than 
those reported for natural zinc-containing proteins which commonly have dissociations 
constants of 10-8-10-13 M [161]. Structure calculations were carried out in the absence of 
explicit Zn2+ ions to avoid conformational search bias and converged toward a structural 
ensemble with two distinct Zn2+ binding sites: the tetracoordinated N-terminal site (Zn-I) 
with weaker binding affinity, and the hexacoordinated C-terminal loop (Zn-II) with 
higher binding affinity (Figure S3.2 and S3.3). Extended X-ray absorption fine structure 
(EXAFS) data corroborated these results, showing that both Zn sites coordinated with 
two Sulfur ligands (cysteines) with a Zn-S distance of 2.3 Å, and at least one site had four 
Zn-N/O ligands while the other site had two to four. These atom ligands can be either 
protein based or water molecules (Figure S3.8). 
The directed evolution process that yielded the artificial enzyme was based only 
on product formation without structural constraints [51]. As a result, the ligase enzyme 
evolved into a new structure with substantially increased conformational dynamics 
compared to the original DNA-binding scaffold [162]. In fact, ligase 10C showed an 
overall increase in structural plasticity and malleability. Although the two zinc fingers 
had heteronuclear NOEs similar to those of the original scaffold, the loop region that 
replaced the recognition helix had much higher flexibility, with heteronuclear NOEs 
below 0.5. These data indicate augmentation of conformational dynamics in the ps-ns 
time scale supported by longitudinal (T1) and transverse (T2) nuclear spin-relaxation 
measurements as well as hydrogen/deuterium exchange data (Figures 3.2a, S3.9 and 
S3.10a). 
A distinct signature of the hRXRα structure is slow (microsecond-millisecond) 
conformational dynamics [162] (Figure S3.10b), which may be correlated with the 
protein’s ability to optimize protein-DNA interactions. The in vitro evolution of hRXRα 
into the RNA ligase redistributed those conformational dynamics, particularly in the 
region N-terminal to the Zn2+ binding site Zn-II (residues 46-53, Figure 3.2b). 
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Figure 3.2-Conformational dynamics of the ligase enzyme 10C.  
(a) Mapping of the heteronuclear NOEs (proxy for fast dynamics on a ps-ns time scale) on ligase 10C. 
Zinc-coordinating residues are labeled. (b) Mapping of the exchange rates (Rex) obtained from relaxation 
dispersion measurements as proxy for slow dynamics (μs-ms timescale). Color gradient and thickness of 
backbone indicate that the ligase fast dynamics is located mostly in the unstructured loop, whereas the slow 
dynamics is located mostly in the region N-terminal to the Zn-II site (residues 46–53) and is potentially 
correlated to catalytic activity. 
 
To probe the substrate binding surface, we carried out an NMR titration with a 
pseudo-substrate that lacked the 2'-hydroxyl group, preventing enzyme turnover (Figure 
S3.11). Chemical shift perturbation mapping of the ligase structure (Figures 3.3a and 
S3.12) indicated that one of the highly perturbed regions in the substrate bound form 
(residues 46-53) corresponds to high values of chemical exchange (slow conformational 
dynamics) in the substrate-free form (Figure 3.2b). Notably, most alanine mutations in 
this region decreased or completely obliterated the enzyme’s activity (Figures 3.3b). 
Specifically, mutations E48A, Y50A and H51A abolished enzymatic activity, whereas 
C47A and C53A caused a 97% reduction in ligase function. These residues’ high 
conservation among evolved ligase variants further demonstrated their importance 
(Figure 3.3c). The combined results suggest that this protein region (residues 46-53) is 
important for substrate recognition and binding and may contain the active site of the 
enzyme. Four of those five mutation-sensitive residues (C47, E48, H51, C53) are good 
potential metal ligands. Many natural enzymes, such as polymerases, that catalyze 
chemical reactions similar to the specific RNA ligation described here use a mechanism 
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involving catalytic divalent metal ion cofactors, which are coordinated jointly by the 
nucleic acid substrates and active site residues of the enzyme [163]. One may speculate 
that upon forming the enzyme-substrate complex some of the mutation-sensitive residues 
in ligase 10C are involved in binding additional Zn2+ ions that facilitate catalysis, but are 
not bound by the protein alone. However, additional experiments studying the enzyme in 
complex with substrate are needed to elucidate the catalytic mechanism of our artificial 
enzyme. 
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Figure 3.3-Substrate binding surface of ligase 10C probed by NMR and alanine scanning.  
(a) Mapping of NMRchemical shift perturbations (intensity changes, ΔI) for ligase 10C shows regions 
affected by formation of the complex with RNAsubstrate. The most perturbed regions are indicated by 
thicker lines and darker colors. Zinc-coordinating residues are labeled. (b) Activity assay of ligase 10C and 
alanine mutants by gel shift. Ligation activity is normalized to the activity of ligase 10C and represents the 
mean value from two independent experiments. Residues with activity below detection limit are shown in 
blue. (c) Sequence conservation analysis of region 45-54 for ligase enzymes generated by directed 
evolution [51]. The sequences were analyzed using the web based application WebLogo (V 2.8.2) from a 
dataset of 49 enzyme sequences. Residues E48, Y50, and H51 (blue) which completely lost activity during 
alanine scanning (see above) were conserved among all sequences. The two residues with 97% reduced 
activity of their alanine mutant were either conserved (Cys53) or had one alternative amino acid (Cys47). 
None of the other residues in this region were conserved. 
3.4 Discussion 
The increased flexibility of the new ligase structure relative to the parent hRXRα 
could potentially originate from their different functional roles. hRXRα is a DNA binder 
and has been proposed to work through an induced-fit mechanism [159]. In contrast, the 
RNA ligase has evolved to function as a catalyst. This role requires additional flexibility 
to optimize interactions with a target molecule and carry out chemical catalysis using 
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transient interactions that occur in excited conformational states rather than through a 
stable, low energy complex [136,164,165]. This argument is supported by an independent 
directed evolution experiment in which the same hRXRα library yielded proteins that 
bind ATP and maintain the original, non-catalytic DNA binding scaffold, but have no 
catalytic function [129]. In contrast, the evolution of the ligase enzyme resulted in a 
different structure and increased dynamics.  
Compared to natural enzymes which evolved over billions of years, the 
laboratory-evolved ligase enzyme contained substantially fewer secondary structure 
elements such as α-helices and β-strands, and instead exhibited increased flexibility. The 
complete reorganization of the starting scaffold during in vitro evolution may have led to 
the loss of these structural elements. This novel structure has not been subjected to 
extensive selection pressure which shaped contemporary enzymes during their natural 
evolution and can therefore be considered an early or primordial catalytic fold. Further 
evolution of this enzyme in vitro or inside a cell will explore if incremental mutations 
lead to structural and dynamic properties more similar to natural enzymes. Although 
flexibility has been suggested to increase the probability of developing new functions 
[152], it also reduces overall protein stability; a trade-off which enzymes must balance 
during evolution. 
3.5 Conclusions 
This report describes what is to our knowledge the first new protein structure 
emerging simultaneously with a novel enzymatic function. This ligase evolved in the 
absence of selection pressure to maintain the protein’s original function (DNA binding). 
Would proteins evolving in nature also more readily adopt new folds and functions if 
they were freed from maintaining their original function? Although the search for such 
examples in nature is still ongoing, the simplified environment of in vitro evolution 
enables us to generate precedents and study basic principles of complex natural 
evolution. Finally, in vitro directed evolution has the potential to produce novel 
biocatalysts for a wide range of applications. The unique structure of the artificial ligase 
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enzyme demonstrates that this approach can successfully generate novel enzymes without 
being limited to known biological folds [166]. 
3.6 Materials and methods 
All chemical compounds used in this study were purchased from Sigma-Aldrich unless 
noted otherwise and were of Molecular Biology Grade, and certified for the absence of 
ribonucleases when used for ligation reactions.  
 
3.6.1 Sequence of RNA ligase 10C. 
MGAPVPYPDPLEPRGGKHICAICGNNAEDYKHTDMDLTYTDRDYKNCESYHKC
SDLCQYCRYQKDLAIHHQHHHGGSMGMSGSGTGY 
 All ligase protein preparations consisted of the sequence above except for point 
mutations in the case of ligase mutants. Note that the sequence HHQHHH functions 
similarly to a 6xHis-tag.  
 
3.6.2 Expression and purification of 15N-labeled ligase protein for NMR studies. 
 Ligase samples were expressed in E. coli BL21-DE3 Rosetta strain cells 
(Novagen). Cells were grown in LB with 36 μg/mL kanamycin overnight at 37˚C. This 
culture was then used to inoculate 1 L of LB medium containing 36 μg/mL kanamycin. 
The cultures were grown to an OD600 of 0.6-0.8 at 37˚C, spun down, and resuspended in 
M9 minimal medium (50 mM Na2PHO4, 22 mM KH2PHO4, 8.5 mM NaCl, 2 mM 
MgSO4, 1 mg/L thiamine, 1 mg/L biotin, 60 μM ZnSO4, 10 g/L dextrose, 1 g/L 15NH4Cl, 
and 36 μg/mL kanamycin, pH = 7.3). Cultures were shaken for 1 h at 37˚C, induced with 
1 mM IPTG, and shaken overnight at room temperature before being spun down and 
stored at -20˚C.  
 Frozen cell pellets were resuspended in lysis buffer (20 mM HEPES, 400 mM 
NaCl, 100 μM ZnCl2, 100 mg/L Triton X-100, 5 mM β-mercaptoethanol, pH = 7.4) and 
lysed using a S-450D Digital Sonifier (Branson). Cell debris was removed by 
centrifugation and the His-tagged ligase protein was purified by affinity chromatography 
using Ni-NTA Superflow resin (QIAGEN). The protein was eluted with acidic elution 
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buffer (20 mM NaOAc, 400 mM NaCl, 0.1 mM ZnCl2, 100 mg/L Triton X-100, 5 mM β-
mercaptoethanol, pH = 4.5) into 1 M HEPES at pH = 7.5, and immediately mixed to 
adjust the pH. Protein purification was evaluated by SDS-PAGE on Ready Gel precast 
gels (Bio-Rad). Elution fractions containing ligase protein were concentrated under high 
pressure in a stirred-cell concentrator unit with a 5,000 MWCO Ultracel Ultrafiltration 
cellulose membrane (Millipore) and dialyzed into FPLC buffer (20 mM HEPES, 150 mM 
NaCl, 0.1 mM ZnCl2, and 0.5 mM β-mercaptoethanol, pH = 7.5). 
 Monomer ligase protein was isolated by size-exclusion chromatography using the 
AKTA FPLC system (GE Healthcare) equipped with a 10 mm x 300 mm column 
(Tricorn) and Superdex 75 resin (GE Healthcare). The separation was carried out in 
FPLC buffer. Fractions containing monomer protein were pooled and concentrated using 
10,000 MWCO Ultra-4 Centrifugal Filter units (Millipore). Purity was assessed by SDS 
PAGE gel (Figure S3.13). 
 
3.6.3 Expression and purification of 15N/13C-labeled ligase samples for NMR studies. 
 Ligase samples were expressed in E. coli BL21-DE3 Rosetta strain cells 
(Novagen). Cells were grown in LB with 36 μg/mL kanamycin overnight at 37˚C, spun 
down, and resuspended in M9 minimal medium (contents as described above, except with 
2 g/L [13C]-dextrose). The resuspended cells were used to inoculate 100 mL of M9 
minimal medium and were grown to an OD600 of 0.6 at 37˚C, at which time the culture 
was used to inoculate 900 mL of M9 minimal medium. The 1 L culture was grown to an 
OD600 of 1.0 at 37˚C, induced with 1 mM IPTG, and shaken overnight at 37˚C before 
being spun down and stored at -20˚C. The 15N/13C-labeled protein was purified in the 
same manner as the 15N-labeled protein samples. 
 
3.6.4 Expression of selectively labeled ligase protein for NMR studies. 
 Ligase samples were expressed in E. coli BL21-DE3 Rosetta strain cells 
(Novagen). Cells were grown in LB with 36 μg/mL kanamycin overnight at 37˚C, spun 
down, and used to inoculate 1 L of selectively labeled M9 medium (40 mM Na2PHO4, 22 
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mM KH2PHO4, 8.5 mM NaCl, 1 mM MgSO4, 50 μM CaCl2, essential vitamins and 
minerals, and 36 μg/mL kanamycin, pH 7.0). To the medium was also added 250 mg of a 
single 15N-labeled amino acid (cysteine, leucine, lysine or tyrosine), 600 mg of the 
remaining 19 unlabeled amino acids and, except for labeling [15N]cysteine, one of the 
following additional amino acid supplements: 900 mg glutamine, asparagine and arginine 
when labeling [15N]lysine; 900 mg valine and isoleucine when labeling [15N]leucine; and 
900 mg phenylalanine, tryptophan, alanine, serine, glycine and cysteine when labeling 
[15N]tyrosine. Cultures were grown to an OD600 of 1.0 at 37˚C, induced with 1 mM IPTG, 
and shaken for 6 h at 37˚C before being spun down and stored at -20˚C. Selectively 
labeled protein was purified in the same manner as the 15N-labeled protein samples. 
 
3.6.5 Generation of ligase mutants. 
 Ligase mutants were obtained by site-directed mutagenesis (QuikChange 
Lightning, Agilent). Plasmid DNA was purified using the QIAprep Spin Miniprep kit 
(QIAGEN). The ligase mutants were verified by DNA sequencing. The primer sequences 
used to generate the indicated mutations in the ligase were designed in accordance with 
the QuikChange Primer Design tool (Agilent) and were as follows:  
K45A F: 5'-CTACACCGATCGAGACTACGCGAATTGTGAGAGCTACC 
K45A R: 5'-GGTAGCTCTCACAATTCGCGTAGTCTCGATCGGTGTAG 
N46A F: 5'-CCGATCGAGACTACAAGGCTTGTGAGAGCTACCATAAGTG 
N46A R: 5'-CACTTATGGTAGCTCTCACAAGCCTTGTAGTCTCGATCGG 
C47A F: 5'-CCGATCGAGACTACAAGAATGCTGAGAGCTACCATAA 
C47A R: 5'-TTATGGTAGCTCTCAGCATTCTTGTAGTCTCGATCGG 
E48A F: 5'-GACTACAAGAATTGTGCGAGCTACCATAAGTGCTCGG 
E48A R: 5'-CCGAGCACTTATGGTAGCTCGCACAATTCTTGTAGTC 
S49A F: 5'-AGACTACAAGAATTGTGAGGCCTACCATAAGTGCTCGGAC 
S49A R: 5'-GTCCGAGCACTTATGGTAGGCCTCACAATTCTTGTAGTCT 
Y50A F: 5'-CTACAAGAATTGTGAGAGCGCCCATAAGTGCTCGGACTTGTG 
Y50A R: 5'-CACAAGTCCGAGCACTTATGGGCGCTCTCACAATTCTTGTAG 
H51A F: 5'-CTACAAGAATTGTGAGAGCTACGCTAAGTGCTCGGACTTGTG 
H51A R: 5'-CACAAGTCCGAGCACTTAGCGTAGCTCTCACAATTCTTGTAG 
K52A F: 5'-ACAAGAATTGTGAGAGCTACCATGCGTGCTCGGACTTGTGC 
K52A R: 5'-GCACAAGTCCGAGCACGCATGGTAGCTCTCACAATTCTTGT 
C53A F: 5'-GTGAGAGCTACCATAAGGCCTCGGACTTGTGCCAGT 
C53A R: 5'-ACTGGCACAAGTCCGAGGCCTTATGGTAGCTCTCAC 
S54A F: 5'-GTGAGAGCTACCATAAGTGCGCGGACTTGTG 
S54A R: 5'-CACAAGTCCGCGCACTTATGGTAGCTCTCAC 
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3.6.6 Expression and purification of ligase mutants.  
 Ligase mutants were expressed in E. coli BL21-DE3 Rosetta cells (Novagen). 
Cells were cultured in 1 l of LB medium with 36 μg/mL kanamycin to a D600 of 0.8–1.0 
at 37°C. Cultures were induced with 1 mM IPTG and shaken for 6 h at 37°C before being 
spun down and stored at −20°C. Ligase mutant proteins were purified by Ni-NTA affinity 
chromatography in the same manner as described for the 15N-labeled protein samples. 
 
3.6.7 Analysis of metal content by ICP-MS. 
 Ligase 10C was purified as described for the 15N-labeled protein samples and then 
dialyzed three times against buffer (100 mM NaCl, 10 mM β-mercaptoethanol and 20 
mM TrisHCl at pH 7.5; pretreated with Chelex 100 beads (Bio-Rad) for 2 h and filtered) 
at a ratio of 1/1,000. The metal content of 14 μM protein was measured by ICP MS 
(Thermo Scientific XSERIES 2 ICP-MS with ESI PC3 Peltier-cooled spray chamber at 
the Department of Earth Sciences, University of Minnesota). 
 
3.6.8 Ligase activity assay for zinc dependence. 
 Zinc was removed from ligase 10C by treatment with ion-exchange resin (Chelex 
100, Bio-Rad). Ligase 10C (5 μM) was incubated with 20 μM HO-substrate, 10 μM 32P-
labeled PPP-substrate base-paired to splint, 20 mM HEPES (pH 7.5), 150 mM NaCl, 500 
μM β-mercaptoethanol and the concentrations of ZnCl2 as indicated in (Figure S3.7) for 6 
h at room temperature. The ligation reactions were quenched with 20 mM EDTA in 8 M 
urea, heated to 95°C for 4 min and separated by denaturing PAGE gel. The gel was 
analyzed using a GE Healthcare (Amersham Bioscience) Phosphorimager and 
ImageQuant software (Amersham Bioscience). 
 
3.6.9 Ligase activity assay of 10C and alanine mutants. 
 5 μM Ligase 10C (or alanine mutant) was incubated for 6 h at room temperature 
in the presence of 20 μM HO-substrate, 10 μM 32P-labeled PPP-substrate/splint, 24 mM 
HEPES (pH 7.5), 130 mM NaCl, 100 μM β-mercaptoethanol, and 120 μM ZnCl2. The 
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ligation reactions were quenched with 20 mM EDTA and 8 M urea, heated to 95°C for 4 
min, and separated by denaturing PAGE gel. The gel was analyzed using a GE 
Healthcare (Amersham Bioscience) Phosphorimager and ImageQuant software 
(Amersham Bioscience). 
3.6.10 Resonance assignment. 
 All NMR data were collected at the University of Minnesota NMR Center. NMR 
spectra were acquired at 298 K on a Bruker spectrometer equipped with a cryoprobe at 
700 MHz and a Varian spectrometer at 600 MHz. The samples were in a buffer of 150 
mM NaCl, 20 mM HEPES and 10 mM β-mercaptoethanol, pH 7.5. Moreover, all protein 
samples were saturated with ZnCl2 by observing changes in HSQC spectra before other 
NMR experiments. Triple resonance spectra such as CBCA(CO)NH and HNCACB [167-
169] were used to assign peaks on 15N-HSQC. All resonances in these two three-
dimensional spectra and 15N-HSQC were picked and fed into the PISTACHIO program 
(National Magnetic Resonance Facility in Madison, WI, USA) [170] to obtain 
preliminary assignments. Final complete assignments were done by manual checks and 
searches. Carbonyl groups and others side-chain carbons were assigned by HNCO and 
C(CO)NH-TOCSY[171]; side-chain protons were assigned by 15N-NOESY-HSQC, 15N-
TOCSY-HSQC, and HC(CO)NH-TOCSY experiments [171] with mixing times of 150 
ms, 60 ms and 12 ms, respectively. 
 
3.6.11 Distance restraints. 
 All proton distance restraints were determined from the cross-peak intensities in 
the NOESY spectra by calibration with HN(i)Hα(i-1) distances located at the C-terminal 
region [172], whose helix propensity was shown by chemical shift index and 3JHNHα 
coupling values [172,173]. The cross-peaks from HN(i)Hα(i–1) distances in that region 
were categorized as medium NOEs, so the intensities of other cross-peaks smaller than 
this intensity range were defined as weak NOEs, and those larger than this range 
belonged to strong NOEs. The upper bounds of distance restraints of strong, medium and 
weak NOEs were given as 2.9 Å, 3.5 Å and 5 Å, respectively, and lower bounds were set 
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to 1.8 Å in all cases. Starting from unambiguously assigned NOEs at the beginning of 
calculation, miscalibrated NOEs were adjusted, and then ambiguously assigned NOEs 
were gradually added into the restraint table during iterative calculation. 
 
3.6.12 Torsion angle restraints. 
 Backbone φ angle restraints were acquired from the HNHA experiment, and the 
quantitative 3JHNHα coupling values were calculated from the intensity ratios of cross-
peaks to diagonal peaks and corrected by 3.7% to account for relaxation [174]. The 
correction is proportional to the rotational correlation time of the protein (3 ns), which 
was measured from one-dimensional TRACT experiment[175]. The φ angle of residue i 
with J-coupling larger than 8.5 Hz was restrained from −160° to −80°, and that with J-
coupling smaller than 6 Hz was restrained from −90° to −40°. Moreover, the ψ angle 
restraints were derived from the 15N-NOESY data. If the intensity ratio of the HN(i)Hα(i) 
cross-peak to the HN(i)Hα(i–1) peak is smaller than one, the ψ(i-1) is restrained from 20° 
to 220°; otherwise, the ψ(i–1) is restrained from 80° to −140° [176,177]. 
 
3.6.13 RDC measurement. 
 The stability of several alignment media for ligase 10C was tested. Using 5% 
neutral and negatively charged acrylamide gel was first attempted, but only weak residual 
dipolar couplings (absolute values <5 Hz) were obtained. Additionally, the samples 
precipitated in both DMPC-D7PC and DMPC-D6PC bicelle preparations. We also tested 
the liquid crystalline medium formed by cetylpyridinium chloride (CPCl) and 1-hexanol 
but had poor results in terms of sample stability. The sample was finally aligned in the 
other liquid crystalline medium made by the mixture of C12E5 (5% alkylpoly(ethylene 
glycol)) and 1-hexanol (r = 0.85) [178]. The residual dipolar couplings of amide groups 
were obtained by measuring the splitting difference between a decoupling HSQC peak 
and a TROSY peak in isotropic solution and anisotropic medium.  
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3.6.14 Structure calculations. 
Simulating annealing protocols were performed in the XPLOR package [179]. An 
extended structure was first generated, and the initial temperature was set at 3,500 K, 
then the temperature was cooled down to 0 K with 15,000 steps. The structure with the 
lowest energy was used for refinement with the initial temperature of 5,000 K and 30,000 
steps. The resulting structure was further refined with RDC data after optimization of the 
parameters Da and Rh. The angle restraints of the zinc coordination geometry were based 
on ideal geometries derived from X-ray data [180,181], which are in quantitative 
agreement with the EXAFS experiments. Distances derived from EXAFS have 
previously been used as restraints in NMR refinement [182,183]. Here, we report a 
structural ensemble of 20 conformers. The PROCHECK statistics show that 76.4% of 
residues are in most favored regions and 21.1% of residues are in allowed regions. 
3.6.15 Zn K-edge EXAFS. 
Ligase 10C protein was fully saturated with excess Zn2+ and then dialyzed to 
remove excess Zn2+. The final protein sample was 1.39 mM in 15 mM Tris, pH 7.5 and 
112.5 mM NaCl. Glycerol (20% v/v) was added to the protein samples to form a glass 
required for the EXAFS experiments. The Zn K-edge X-ray absorption spectra of ligase 
10C were measured at the Stanford Synchrotron Radiation Lightsource (SSRL) on the 
16-pole, 2-T Wiggler beamline 9-3 under standard ring conditions of 3 GeV and ~200-
mA ring current. A Si(220) double-crystal monochromator was used for energy selection. 
Another optical component used for the experiment was a cylindrical Rh-coated bent 
focusing mirror. Spectra were collected in the fully tuned configuration of the 
monochromator. The solution samples were immediately frozen after preparation and 
stored under liquid N2 until measurement. During data collection, the samples were 
maintained at a constant temperature of ~6 K using an Oxford Instruments CF 1208 
liquid helium cryostat. Data were measured to k = 16 Å−1 by using a Canberra Ge 100-
element monolith detector. Internal energy calibration was accomplished by simultaneous 
measurement of the absorption of a Zn foil placed between two ionization chambers 
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situated after the sample. The first inflection point of the foil spectrum was fixed at 
9,660.7 eV. Data presented here are a 15-scan average. The data were processed by 
fitting a second-order polynomial to the pre-edge region and subtracting this from the 
entire spectrum as background. A five-region spline of orders 2, 3, 3, 3 and 3 was used to 
model the smoothly decaying post-edge region. The data were normalized by subtracting 
the cubic spline and assigning the edge jump to 1.0 at 9,680 eV using the Pyspline 
program [184]. Theoretical EXAFS signals χ(k) were calculated by using FEFF 
(Macintosh version 8.4) [185-187]. Initial model was based on the Zn(Cys)2(His)2 active 
site in a zinc finger protein (1MEY)[188]. On the basis of the preliminary fits, the models 
were modified to accommodate a six-coordinate active site (4 Zn-N/O and 2 Zn-S(Cys)). 
 The theoretical models were fit to the data using EXAFSPAK [189]. The 
structural parameters varied during the fitting process were the bond distance (R) and the 
bond variance σ2, related to the Debye-Waller factor resulting from thermal motion and 
static disorder of the absorbing and scattering atoms. The nonstructural parameter E0 (the 
energy at which k = 0) was also allowed to vary but was restricted to a common value for 
every component in a given fit. Coordination numbers were systematically varied in the 
course of the fit but were fixed within a given fit. 
3.6.16 Accession codes  
Protein Data Bank: the accession code for ligase 10C is 2LZE. Biological Magnetic 
Resonance Data Bank: the accession number for ligase 10C is 18749. 
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3.7 Supplementary information 
Table S 3.1- Summary of NMR structural statistics of 20 conformers. 
 The RMSD of the structural ensemble is calculated within well-structured regions (residues 17-35 and 49-
69).  
 Protein 
NMR distance and dihedral constraints  
Distance constraints  
    Total NOE 354 
    Intra-residue    106 
    Inter-residue 248 
      Sequential (|i – j| = 1) 162 
      Medium-range (|i – j| < 4) 34 
      Long-range (|i – j| > 5) 52 
      Intermolecular 0 
    Hydrogen bonds 0 
Total dihedral angle restraints 34 
    φ 15 
    ψ 19 
Total RDCs 
    Q (%) 
 
26 
14.6 
Structure statistics  
Violations (mean and s.d.)  
    Distance constraints (Å)     0.1 (0.01) 
    Dihedral angle constraints (º) 1.3 (0.4) 
    Max. distance constraint violation (Å) 0.8 (0.4) 
    Max. dihedral angle violation (º)     5.7 (1.6) 
Deviations from idealized geometry  
    Bond lengths (Å)     0.008 
    Bond angles (º) 1.0 
    Impropers (º) 0.5 
Average pairwise r.m.s. deviation** (Å)      
    Heavy      1.4 
    Backbone   0.8 
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Table S 3.2- Thermodynamic parameters for Zn2+ binding determined by Isothermal Titration 
Calorimetry. 
After completely removing the Zn2+ from the protein with Chelex 100 chelating ion exchange resin 
(BioRad), 5 μM ligase enzyme was slowly titrated with 400 μM ZnCl2 solution, and the heat release was 
monitored using a MicroCal VP-ITC instrument (GE Healthcare). All samples contained at 150 mM NaCl, 
20 mM HEPES, 10 mM β-mercaptoethanol, and pH 7.5, and the data were fitted with a sequential two-site 
binding model. The values represent the average of three measurements. 
 Average value Standard deviation 
Kd1 (μM) 3.0 0.6 
ΔH1 (kcal/mole) 122.9 14.8 
ΔS1 (cal/mole/°) 437.7 49.7 
Kd2 (μM) 92.8 8.9 
ΔH2 (kcal/mole) -123.7 13.3 
ΔS2 (cal/mole/°) -396.3 45.0 
 
 
Table S 3.3- EXAFS least squares fitting results for ligase 10C. 
Coordination/Path R(Å) [a] σ2(Å2)[b] E0 (eV) F
 [c] 
4 Zn-N 2.00 (0.005) 731 
-12.3 0.18 
2 Zn-S 2.30 (0.003) 453 
6 Zn-C 3.00 (0.015) 1,077 
12 Zn-C-N 3.09 (0.034) 1,077 [d] 
6 Zn-C 4.16 (0.012) 169 
6 Zn-C-N 4.19 (0.013) 169 [d] 
6 Zn-C-N 4.30 (0.014) 169 [d] 
[a] The estimated standard deviations for the distances were calculated by EXAFSPAK and are given in 
parentheses (see also Figure S3.8 caption).  
[b] The σ2 values are multiplied by 105.  
[c] Error is given by Σ[(χobsd – χcalcd)2 k6]/Σ[(χobsd)2k6].  
[d] The σ2 value for the Zn-C (single scattering) and Zn-C-N (multiple scattering) paths were linked to be 
the same value. 
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Figure S 3.1-Summary of the NOEs observed from NOESY spectra.  
(a) Horizontal bars show the presence of NOE signals between residues. Bar thickness corresponds to the 
NOE intensity. (b) Long-range NOEs observed in ligase 10C. 
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Figure S 3.2-Convergence of the structural ensemble of 20 conformers.  
(a) Average backbone RMSD of the conformational ensemble. (b) Correlation between experimental RDC 
values and average back-calculated RDC values from the ensemble. 
Figure S 3.3-The structural ensembles are calculated before and after incorporating Zn2+ ions into 
the coordinates.  
(a) Ensemble of 20 lowest energy conformers (residues 17-69) selected from 100 structures. The NOEs, 
torsion angles, and RDC values were included in these calculations. Note that the two Zn2+ ions and 
coordination were not included. (b) Ensemble of 20 lowest energy conformers (residues 17-69) obtained 
including Zn2+ ions and coordination. The two Zn2+ ions are shown as blue spheres. The side chains 
involved in the coordination are displayed in red (H18, E28(OD2), C57, C60, D65(OD1), and C20, C23, 
D34(OD1)) and, additionally, both zinc binding sites each contain a single water ligand (not shown) 
resulting in a hexacoordinated and tetracoordinated sites, respectively. The backbone RMSD between the 
well-structured regions (residues 17-35 and 49-69) of the ensembles with Zn2+ and without Zn2+ is 0.52 Å. 
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Figure S 3.4-Zn2+ titration into 15N-labeled ligase 10C monitored by NMR.  
A selected region of HSQC spectra recorded during Zn2+ titration is shown. Residues of partially Zn2+-
saturated sample displayed slow exchange on the NMR time scale between forms bound to one or two 
Zn2+.  
 
 
Figure S 3.5-HSQC spectra recorded upon Zn2+ titration.  
Molar ratios of ligase 10C to zinc were: 1) 10C:Zn=1:0, 2) 10C:Zn=1:1, 3) 10C:Zn=1:2, 4) 10C:Zn=1:3, 5) 
10C:Zn=1:4, 6) 10C:Zn=1:6. 
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Figure S 3.6-Zn2+ titration into the ligase enzyme monitored by ITC.  
Samples contained 5 μM ligase 10C, 150 mM NaCl, 20 mM HEPES, 10 mM β-mercaptoethanol, pH 7.5 
and were measured by Isothermal Titration Calorimetry using a MicroCal VP-ITC instrument (GE 
Healthcare). (a) The graph represents the raw data for the blank titration (buffer without ligase). (b) The 
graph represents raw data for the Zn2+ titration of ligase 10C. (c) The figure shows the heat release of the 
Zn2+ titration of ligase 10C after subtracting the blank titration. The data is fit to a model of two binding 
sites. The data can be fitted to models with two or more Zn2+ binding sites, however, the fit does not 
improve significantly with n>2. The Zn2+ titration was carried out in triplicate and the errors are 
summarized in the Table S3.2.   
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Figure S 3.7-Zn2+ dependence of ligase activity.  
The maximum activity was observed at 145 µM Zn2+. Towards lower Zn2+ concentrations the activity 
sharply drops, matching the expected behavior predicted from the dissociation constants measured by 
Thermocalorimetry. Towards higher Zn2+ concentrations, the activity also decreases but more slowly. One 
possible explanation is that Zn2+ at high concentrations might also bind to additional sites with lower 
affinity thereby reducing the activity. Error bars represent one standard deviation. Ligation activity for 
samples at 0.1, 1, 5 and 10,000 μM ZnCl2 was below the detection limit of 1%. 
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Figure S 3.8-Analysis of zinc coordination by EXAFS spectroscopy (Extended X-ray Absorption Fine 
Structure).  
(a) The k3 weighted Zn K-edge EXAFS (inset) and their corresponding non-phase shift corrected Fourier 
transforms for ligase 10C are presented. The experimental data are shown as black lines and the fit as red 
lines. The best-fit parameters are given in Table S3.3. While a coordination with four ligands is most 
commonly observed for zinc ions, a coordination geometry including six ligands has been observed in 
natural proteins numerous times [180,190]. The first shell coordination number was varied from four-
coordinate to six-coordinate. In each case the number of Zn-S and Zn-N/O components was systematically 
varied to obtain the best F value. These fits show that the data are most consistent with a six-coordinate site 
with 2 Zn-S and 4 Zn-N/O components. A 1:1 occupation of the two sites modeled from NMR analysis 
would have resulted in best-fit with 3 Zn-N/O and 2 Zn-S coordination. However, the process of dialysis 
(removal of excess Zn is necessary for EXAFS experiments) may lead to stripping of some Zn from the 
weakly bound N-terminal site. This leads to an increase in the number of six-coordinate sites over four-
coordinate sites in the protein and results in a best-fit first shell with more than 3 Zn-N/O paths. The 
EXAFS data are dominated by first shell Zn-N/O and Zn-S, while second and third shells are significantly 
weaker. The second and third shells were fit with single (Zn-C) and multiple-scattering (Zn-C-N) 
theoretical paths generated using a representative Zn-N(His) model. These weak features are due to a 
combination of single and multiple scattering from the amino acid ligands. The multiple scattering features 
are different from characteristic Zn-N(His)n [191] or ZnS(Cys)n [192] systems due to interference between 
second shell components of Cys and His ligands. Note that standard deviations in bond distances obtained 
from EXAFSPAK assume the use of raw, low-noise data. Although the data quality presented here are 
quite high, it is important to note that in the presence of several single and multiple scattering paths, the 
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choice of a specific path to represent an average of multiple paths will also affect the standard deviations. 
Typically second shell paths have errors of the order 0.05 to 0.1 Å. Furthermore these standard deviations 
do not reflect the fact EXAFS analysis typically underestimates bond distances (relative to 
crystallography). The protein samples used for EXAFS analysis were extensively dialyzed and had no 
extraneous source of sulfur, precluding non-protein based Zn-S ligation. A visual inspection of the FEFF fit 
presented here shows that the first peak (corresponding to Zn-N/O paths) in the Fourier Transform is a 
slightly poorer fit relative to the second peak (corresponding to Zn-S paths). In an attempt to improve the 
fits and to differentiate between 3 Zn-N/O and 4 Zn-N/O fits, split first shell fits were performed. 
Significant statistical improvement was not observed. (b) The Rsq values (Σ[(χobsd – χcalcd)2 k6]/Σ[(χobsd)2k6]) 
for four- to six- coordinate first shell fits are presented as a function of increasing number of Zn-S ligands 
with concomitant decrease in the number of Zn-N/O ligands. ( ) four-coordinate, ( ) five-coordinate. ( 
) six-coordinate. The Rsq of the four-coordinate fit is significantly worse than that of the five- or six- 
coordinate fits. Note that although the best Rsq value is obtained with 4 Zn –N/O and 2 Zn-S ligands, the 
five coordinate fits with either 3 Zn-N/O and 2 Zn-S or 2 Zn-N/O and 3 Zn-S ligands also have reasonably 
low Rsq values. For the 2 Zn-N/O and 3 Zn-S fit to be correct, the two Zn sites need to have 2 Zn-S and 4 
Zn-S ligands, respectively. Such a structure is ruled out by NMR data, which show that the sites do not 
have more than two S-based ligands. Since the first shell coordination number error can be up to 20%, it is 
difficult to differentiate between the 4 Zn-O/N and 3 Zn/O fits with a high level of statistical confidence. 
Note that both the 4 Zn-N/O and 3 Zn-N/O fits indicate that the high Zn-affinity site is six-coordinate. Six-
coordinate Zn sites account for at least 11% of all Zn sites in biology based on NMR and crystallography 
studies [190]. EXAFS studies with cysteine ligands are typically limited to four- and five-coordinate sites 
[193]. Studies have been performed on six-coordinate sites, but typically with all light atom ligands [194]. 
In general, a comparison of total EXAFS intensity can give an insight into the coordination number but the 
presence of two different first shell ligands (N/O and S) modulates the EXAFS data strongly, making an 
accurate comparison of EXAFS data between two systems with different coordination numbers difficult 
[193]. In such a situation, the error in first shell coordination number determination can be greater than 
20%. Since the EXAFS data are best fit with between 3 and 4 light atom ligands, the higher error indicates 
that the second site can be between tetra- and septa-coordinate. Since, a seven coordinate site has no 
biological precedence, the second site is between tetra- and hexa-coordinate. 
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Figure S 3.9-Structure and conformational dynamics probed by NMR experiments.  
(a) Chemical shift indexes (ΔCα-ΔCβ), steady-state NOE, longitudinal relaxation rates (R1), transverse 
relaxation rates (R2), and R1/R2 ratios as determined by NMR spectroscopy (unassigned residues are 
marked with an "X"). The errors are estimated by the signal-to-noise (H-X NOE), standard deviations of 
the fitting (R1, R2, and R1/R2), or duplicate experiments (ΔR2). The two zinc fingers are highlighted with 
dashed red lines. (b) The decrease of peak intensities due to H/D exchange was mapped onto one NMR 
conformer (residues 17-69 are displayed). The intensity of the peaks was normalized to a reference HSQC 
spectrum of the ligase 10C in 10% D2O. The sample was lyophilized and dissolved in the same volume of 
80% D2O. After 6 minutes, the HSQC spectrum was acquired and compared with the initial spectrum to 
monitor solvent exposed amide groups. The solid red line in the diagram represents the average intensity 
retention plus 2σ.   
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Figure S 3.10-Mapping of the conformational dynamics of the DNA binding domain (hRXRα).  
(a) Heteronuclear NOEs (proxy for fast dynamics on a picosecond-nanosecond time scale) on the structure 
of hRXRα [159]. (b) Exchange rates (Rex) obtained from relaxation dispersion measurements as a proxy for 
slow dynamics (microsecond-millisecond time scale). The color gradient and the thickness of the backbone 
indicate the intensity of the motions.  
Figure S 3.11-Chemical structure of inactive ligation substrate. 
Substitution of the 2'-hydroxyl group of the terminal nucleotide in the HO-substrate with a 2'-deoxy 
modification (red box) results in inactivation of the ligation reaction. Ligation of active substrates occurs 
between a 5'-triphosphorylated RNA (PPP-substrate) and the 3'-hydroxyl group of the second RNA (HO-
substrate) while both RNAs are base-paired to a complementary oligonucleotide (splint). The dashed arrow 
symbolizes the proposed bond formation.  
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Figure S 3.12-Titration of RNA substrate into ligase 10C monitored by NMR spectroscopy.  
(a) The ligase enzyme (300 μM) was titrated with the inactive RNA ligand in 150 mM NaCl, 20 mM 
HEPES, 10 mM β-mercaptoethanol, and pH 7.5. The HSQC spectra during the titration showed no 
significant changes in chemical shifts. (b) Slices of a selected peak (H51) in HSQC spectra during ligand 
titration showed significant line-broadening. 
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Figure S 3.13-Purity and identity of purified ligase 10C.  
SDS-PAGE gel (NuPAGE 4-12% Bis-Tris gel, Invitrogen) Coomassie stained of ligase 10C purified by 
nickel affinity chromatography and size exclusion chromatography and 10-250 kDa ladder P7703S (New 
England Biolabs) used as a marker. The identity of ligase 10C was confirmed by MALDI mass 
spectrometry yielding a characteristic [M+H]+ signal at m/z = 9,648 ± 1.4 (± s.d. from five independent 
measurements), which is consistent with the expected mass of the ligase 10C without the N-terminal 
methionine (MW = 9,648.7 Da). The purity of labeled constructs and all mutants matched that of the 
purified ligase 10C shown here. 
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Chapter 4 : Comprehensive deletion libraries mediated by in vitro 
transposition 
This chapter describes unpublished experiments. Dr. Seelig and I designed the 
experiments and interpreted the results. I performed all the experiments. Joshua Baller 
and Lauren Mills from the Minnesota Supercomputing Institute (MSI) analyzed the Next 
Generation Sequencing (NGS) data, generated the related figures, and contributed to the 
interpretation of the NGS results. 
4.1 Summary 
We present a novel method to generate large libraries of >10,000 random deletion 
mutants of a given gene. This approach is based on in vitro transposition and routine 
molecular biology techniques such as PCR, restriction digestion and ligation. The method 
is easy to implement and can generate libraries in three to four days. This technique can 
be applied to the biochemical characterization of proteins and nucleic acids and in vitro 
directed evolution studies of proteins. We used the generated library as input for the 
directed evolution by mRNA display of the artificial ligase 10C yielding functional 
variants with deletions of up to 18 of a total of 96 amino acids. 
4.2 Introduction 
Several studies highlight the importance of deletions in protein evolution. For 
example, analysis of natural proteins or proteins derived from in vitro evolution, showed 
that deletions of up to 40 amino acids within loop regions can be structurally tolerated 
[195]. The Indel PDB database [196] provides numerous examples for deletions that are 
not only found in loops and unstructured regions, but also in alpha helices and beta 
sheets. Proteins with indels are also highly represented in essential proteins, and are very 
common in protein networks, where they show a high level of connectivity, suggesting 
important regulatory roles [197]. Finally, deletions can result in better catalytic and 
biophysical properties [198-200]. Given the importance of deletions, their impact on 
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protein properties needs to be extensively studied in order to further our knowledge of 
evolutionary mechanisms, and accelerate the discovery of improved variants. 
Most commonly in directed evolution experiments large libraries of protein 
variants are created by introducing point mutations [201] or by recombination [202]. On 
the other hand, usually only few deletion variants are generated on the basis of structural 
information [199,203,204]. This approach has resulted in proteins with increased 
stability, however a more thorough and efficient investigation of the effects of deletions 
would require the generation of large libraries of deletion mutants in a combinatorial 
fashion. While methodologies to generate such libraries exist, they have undesired 
drawbacks. They are either sequence specific as they require to design primer pairs for 
each deletion mutant to be generated [205], or they employ nucleases such as DNaseI or 
exonuclease III to degrade the target gene to the desired lengths [198,206,207]. The 
activity of these enzymes is notoriously difficult to control, and reaction conditions, such 
as time or enzyme concentration, usually require extensive optimization to avoid over-
digestion [198,206,207]. 
In order to simplify the procedures required to build libraries of deletion variants, 
we developed a method based on in vitro transposition mediated by the MuA transposase 
[208]. This approach overcomes the two drawbacks mentioned above, and generates a 
library of relatively unbiased and evenly distributed deletions. We used the MuA 
transposition system because it has been well characterized, and its features are ideal to 
develop a generally applicable method to create random deletions. First, the target site 
preference of MuA is low, with insertions occurring randomly along the target sequence 
[208-210]. Second, standard reaction conditions for MuA have been defined that can be 
employed for any target DNA, hence no optimization of the transposition reaction is 
needed. When donor (transposon) and enzyme are mixed in the presence of an excess of 
target for a short time, single insertions are obtained [208]. The MuA transposition 
system has been used for several applications such as DNA sequencing [211] and protein 
engineering [212], highlighting its efficiency and wide applicability. 
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We validated our method by creating a deletion library of the artificial RNA 
ligase enzyme 10C. Our goal was to identify active deletion mutants amenable to 
crystallization. The structure of ligase 10C comprised a well-structured core framed by 
highly dynamic termini. In addition, the structured core also contains a flexible internal 
loop region. The flexibility in those three regions likely prevented previous attempts of 
crystallizing ligase 10C. However, it is conceivable that some of those dynamic regions 
are less important for catalytic function and dispensable, hence they could be removed to 
promote crystallization. Yet, rational prediction of tolerable deletions has been 
notoriously difficult in general, and for ligase 10C in particular as the active site of this 
enzyme is still unknown. Therefore, we decided to employ a directed evolution approach. 
We used the deletion library of ligase 10C as input for an mRNA display selection to 
isolate active shorter variants that will eventually be screened for crystallization. 
In order to build the deletion library, we first generated two separate sub-libraries 
of 5' and 3' terminal gene fragments by transposition and PCR. These sub-libraries were 
randomly recombined by restriction digestion and ligation to obtain a library comprising 
both terminal and internal deletions. We validated library coverage and distribution of the 
deletions by next generation DNA sequencing  
  
4.3 Results  
4.3.1 Library construction 
We created a library of random internal and terminal deletions of variable length 
within a given gene. We used the ligase 10C gene as template to test the approach and to 
subsequently perform an mRNA display selection with the resulting library to identify 
functional deletion variants. In view of the mRNA display procedure, prior to starting the 
deletion protocol we appended a FLAG peptide sequence by PCR to allow purification of 
the fusions during the selection. 
The first step of our protocol was a transposition reaction (Figure 4.1) which 
resulted in random insertions of the transposon in the gene of interest. Subsequently, two 
separate PCR reactions were performed to generate sub-libraries of 5' and 3' fragments 
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(where the 5' fragments contain 3' terminal deletions, and the 3' fragments contain 5' 
terminal deletions). Each PCR contained one primer that binds to the constant region at 
the respective terminus of the gene of interest, and a second primer that binds to the 
transposon. As a result, the PCR products consisted of 5' and 3' fragments of our gene 
with part of the transposon sequence appended (Figure 4.1, step 2). The two PCR 
products were then processed through a series of digestion and ligation reactions to 
remove the transposon sequence and randomly connect the two sub-libraries to generate 
the final deletion library. 
We set up transposition reactions according to manufacturer instructions and 
included a negative control by inhibiting MuA transposase with 10 mM EDTA, and 
heating the reaction for 10 minutes at 75°C before adding the target gene. When the 
transposition reaction was amplified by PCR (Figure 4.2, lane TR) two ensembles of 
random length fragments consistent with the expected range of lengths of DNA were 
observed (957-1,218 bp for the 5' fragment sub-library; 1,247-1,514 bp for the 3' 
fragment sub-library). On the contrary, when the inhibited transposition reaction (IT), the 
transposon DNA alone (T), or the target gene ligase 10C alone were amplified, no smears 
were observed. These results indicate that the smears were a result of the specific 
amplification of the transposition product. For the 5' fragment sub-library a small amount 
of products at about 300 bp length was observed. Furthermore, amplification of the 
transposon alone (T) resulted in a band running at about 350 bp when primers to amplify 
the 5' fragment sub-library were used. These bands were likely the result of mis-priming, 
in fact optimization of the annealing temperature significantly decreased their amount 
(data not shown). 
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Figure 4.1-Overview of method to generate random deletions.  
(1) A transposition reaction was performed to obtain random insertions of the transposon into the target 
gene and generate transposition products. (2) Subsequently random 5' and 3' terminal truncations of the 
gene were amplified in two separate PCR reactions, with primer couples in which one primer bound to the 
5' or 3' constant regions of the target gene, and the other to a region on the transposon. (3) The digestion 
with BsaI created unique overhangs in each library. (4) Libraries were ligated to a linker DNA (pUC19 
fragment *) which contained no MlyI sites. (5) The product of ligation was treated with MlyI to remove the 
transposon sequence. (6) Intramolecular ligation joined the 5' and 3' terminal fragments of the gene. (7) 
This circular library was linearized by PCR with primers complementary to the termini of the original gene. 
(8) The final library of deletion variants of the desired size range was isolated by gel electrophoresis.  
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Following PCR amplification, the two products were digested with BsaI, and ligated to a 
long linear linker DNA. BsaI is a type IIS restriction enzyme which cuts outside of its 
recognition sequence. This allowed us to design unique cut sites for each sub-library to 
prevent ligation of two fragments of the same kind to the linker. As linker we used a 
segment amplified out of the plasmid pUC19 (indicated as pUC19* in figure 4.1). This 
segment does not contain cut sites for the restriction endonuclease MlyI. This enzyme 
was used in the following step to digest the ligation product and remove the transposon 
sequences from the sub-libraries. 
 
 
Figure 4.2-Agarose gel (1%) of PCRs with primer pairs to amplify 5' and 3' fragment sub-libraries in 
presence of different templates.  
TR = transposition reaction; IT = inhibited transposition reaction; T = transposon; 10C = target gene coding 
for ligase 10C; M = Marker (100bp ladder); W = water (negative control).  
  
After ligation (Figure S4.1) we expected a smear in the range 3,531-4,059 bp and we 
obtained a band around 4,000 bp. After removing the transposon by digestion with MlyI 
(Figure S4.2) we obtained a smear in the expected range (1,434 bp-1,962 bp) (Figure 
S4.2), with an overrepresentation of shorter sequences. The two transposon sequences of 
904 bp and 1193 bp were successfully removed as indicated by the presence of two bands 
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at the expected length. The digestion product (1400-2000 bp) was purified, circularized, 
and used as template to amplify the final library. We gel purified the DNA in the range of 
interest from 53 bp to 288 bp, which represent the full length gene and deletion of the full 
sequence (except the regions for primer binding) respectively. As expected, we obtained 
a smear from about 300 bp to less than 100 bp (Figure 4.3, squared bracket). For quality 
control, the final deletion library was sequenced by next generation sequencing.  
 
 
 
Figure 4.3-Agarose gel (1%) of deletion library after gel extraction and desalting.  
M= Marker (2 log ladder); DL=Deletion library.  
 
 
4.3.2 Next Generation Sequencing analysis 
We conducted next generation sequencing analysis of our final deletion library to 
assess the efficiency of our method to generate a large number of deletion mutants 
randomly distributed throughout the starting gene. Sequencing yielded 10,491 unique 
sequences, which represented 36% coverage of the maximum theoretical complexity 
(27,612 sequences; calculated according to eq. 2 in section 4.6.7). In order to verify if 
there were any biases in the deletion distribution, the 10,491 sequences were aligned to 
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count the number of times each nucleotide position was deleted. The observed 
distribution (Figure S4.5, red line) was compared to the theoretical distribution, which 
was calculated for 100% coverage of the theoretical complexity (Figure S4.5, blue line). 
This comparison showed there is a slight bias for deletions towards the 3' end of the gene 
(Figure S4.5). In addition, we observed that sequences with deletions less than 20 bp in 
length are underrepresented by about two orders of magnitude (Figure S4.4). These two 
biases could be explained by the preferential amplification of shorter sequences during 
the PCR amplification of the 5' and 3' fragment sub-libraries (Figure 4.1, step 2), and by a 
potential presence of preferred transposition sites at the 3' of the target DNA. This is in 
agreement with previous findings which showed that although the process of 
transposition is random, some sites can be preferred [208-210]. Despite these biases, the 
sequencing data demonstrated that the method generated random deletions ranging 
widely in their length and in their position along the target sequence. 
 
4.3.3 Set up of the mRNA display selection  
Our goal was to isolate shorter variants of the ligase 10C, ideally catalyzing the 
reaction faster than the wild type and amenable to crystallization. Deletion of residues at 
the termini is a strategy that had been successfully employed to favor protein 
crystallization [203]. However, given the highly dynamic structure of the protein it would 
be difficult to rationally identify disordered regions that upon deletion could favor 
crystallization. We hence decided to take a directed evolution approach as it can test 
many variants at the same time. The deletion library of 10C was used as input for an 
mRNA display selection of shorter active variants that could then be tested for 
crystallization. To further increase the diversity at the beginning of the in vitro selection, 
we also prepared two additional libraries: a deletion library of ligase 10C previously 
mutated at random by error-prone PCR, and a double deletion library by reapplying the 
procedure described in this chapter to the deletion library generated previously. In order 
to isolate both more and less active variants we performed two selections in parallel with 
different selective pressures: 5 minutes and 60 minutes reaction time.  
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4.3.4 In vitro selection for ligase variants  
The mRNA display procedure was performed for 6 cycles of selection and 
amplification as published previously [51,52], and also reported in sections 4.6.8 and 
1.5.2 of this thesis. The percentage of cDNA bound to the streptavidin resin was 
calculated with equation 3 in section 4.6.8 to monitor selection progress.  
For the ‘5 min selection’ the percentage of bound cDNA increased from 0.03% 
after round 1 to 3.5% in round 5 and then decreased to 1.4% in the 6th round (Figure 4.4, 
black bars). For the ‘60 min selection’ we observed an increase in the percentage of 
cDNA bound from 0.18% to 5% in round 3. In the subsequent rounds 4-6 the percentage 
varied between 2.3% and 4% (round 6) (Figure 4.4, grey bars).  
The PCR amplification of the eluted cDNA after round 3 of the ‘60 min selection’ 
yielded a clearly discernible DNA band in the agarose gel of the same length as the 
original full-length gene (332 bp). Apparently, the original gene was preferentially 
enriched, while the smear representing shorter deletion variants was disappearing (data 
not shown). In order to specifically favor and therefore enrich deletion variants over the 
full-length gene, after rounds 3-5 of the ‘60 min selection’, we isolated DNA shorter than 
the original gene (approximately 300 bp to 100 bp) by gel electrophoreses of the PCR 
product and used it as input for the following round. The removal of the band at 332 bp 
explained the drop in signal observed in rounds 4 to round 6. Despite the repeated 
removal by gel extraction, the band at 332 bp reappeared after every round as it was 
enriched during the selection step. 
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Figure 4.4-Progress of in vitro selections for ligases using a 5 minute (black bars) and 60 minute (grey 
bars) incubation time during the selection step. 
 
The signal increase from round 5 to round 6 of the ‘60 min selection’ can instead 
be explained by the enrichment of active deletion variants. An SDS PAGE gel of aliquots 
taken at each step of round 6 of the ‘60 min selection’ (Figure 4.5B), showed the 
enrichment of shorter active variants not observed in previous rounds (lower band in the 
brackets in figure 4.5B). Comparison of the ligation reaction (right-most lane ‘Rxn’) to 
purified material from the preceding step (lane ‘Flag II’), showed the appearance of two 
bands at a higher molecular weight, which represent ligation product caused by the 
covalent link of the 3'-OH substrate to the 5'-PPP substrate, indicating that both bands 
represent active clones. In contrast, the ‘5 min selection’ was mostly enriching variants of 
the same length as ligase 10C (Figure 4.5A), as indicated by the presence of only one 
band shifting up in the ligation reaction (lane ‘Rxn’). 
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Figure 4.5-Gel electrophoresis of mRNA-displayed proteins after individual steps of round 6 of the 
selection (SDS PAGE).  
(A) Gel for ‘5 min selection’. (B) Gel for ‘60 min selection’. TL: translation; OdT: eluate after 
purification by oligo-(dT) cellulose chromatography; Flag: eluate from Flag affinity purification; Cold RT: 
reverse transcription with no 32P-α-dATP added (only 35S-Met label on protein) to verify efficiency of 
reverse transcription; Hot RT: reverse transcription with 32P-α-dATP (label on cDNA); Dialysis: sample 
recovered after dialysis in Flag buffer; Flag II: eluate from second Flag affinity purification; Rxn: ligation 
reaction with 3'-OH biotinylated substrate.  
 
cDNA from round 6 of both selections was amplified by PCR (Figure 4.6). Consistent 
with the results observed by SDS PAGE gel, in round 6 of the ‘60 min selection’ two 
major bands were observed at 332 bp and at about 275 bp, respectively. The ‘5 min 
selection’ yielded a main band at 332 bp.  
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Figure 4.6-Agarose gel electrophoresis of PCR products from cDNA eluted in round 6 for both 5 min 
and 60 min selection.  
For the ‘5 min selection’, the presence of a major band running at the same length of ligase 10C (marked 
with a dot) is consistent with a similar observation in the SDS PAGE gel in figure 4.5A. In the ‘60 min 
selection’, an additional major band (marked by an asterisk) at about 275 bp is present, consistent with the 
two bands in figure 4.5B. 
 
4.3.5 DNA sequencing analysis of enriched clones from round 6 of selection 
For both selections, cDNA after round 6 was cloned into plasmids and sequenced. 
We obtained 68 sequences for the ‘5 min selection’ and 40 sequences for the ‘60 min 
selection’ which were aligned to the original 10C sequence. After manual inspection of 
the alignments we removed any short peptides of only 20-47 amino acids in length, 
which were composed only of the first 13 amino acids from the N-terminus 
(MDYDDDDKGAPV) and of 8 amino acids at the C-terminus (MSGSGTGYStop), and 
of duplications of these sequences. Since these peptides were missing crucial regions 
such as the putative zinc and substrate binding site [127], we reasoned that these peptides 
were selection artifacts and highly unlikely to possess activity. The remaining 54 
sequences from the ‘5 min selection’ were either wild type ligase 10C (63%) or point-
mutants thereof (37%), but no deletions variants were detected. In addition, a single 
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sequence with a one amino acid insertion causing a frame shift near the C-terminus was 
observed. Of the remaining 18 sequences from the ‘60 min selection’, 15 sequences 
(83%) were either 10C wild type (7 sequences) or had point mutations (8 sequences). The 
other 3 sequences (17%) were deletion variants missing 13 and 18 amino acids near the N 
terminus. In particular, the 18 amino acids deletion corresponded to a deletion of 54 bp in 
the original 332 bp DNA, resulting in a band of 278 bp. This size was consistent with the 
lower molecular weight band observed after PCR amplification of the cDNA resulting 
from the 6th round of selection (Figure 4.6, band marked by an asterisk). Interestingly, 
sequences with mutations in the putative zinc binding sites (residues 17-35 and residues 
49-59) were present in multiple copies. In particular M35V appears four times and M35T 
twice. Furthermore, D43Y appears four times. The double mutant M35V/D43Y is present 
in duplicate. In addition, one of the clones from the 5 minutes selection contains 5 point 
mutations, mainly distributed in the flexible termini of the protein structure.  
 
Figure 4.7-Alignment of selected variants of ligase 10C from cDNA after round 6 of the 5 min and 60 
min selections.  
Variants containing a 13 and 18 amino acids deletion (E11, F12, G11) were isolated during the ‘60 min 
selection’. In addition, variants with point mutations were isolated from both selections. Top sequence is 
reference wild type ligase 10C (10C wt). The second sequence represents wild type ligase 10C modified by 
addition of the FLAG peptide for purification purposes during each cycle of selection and amplification. 
Numbering of residues is set to match numbering used to discuss ligase 10C structure in chapter 3. 
 
 92 
 
4.4 Discussion 
Analysis of sequences and structures of naturally and in vitro evolved proteins 
reported that for some select proteins deletions of up to 40 amino acids can be accepted 
without significantly altering tertiary structure [195]. Furthermore, laboratory 
experiments showed that deletions can in some cases result in increased thermostability 
of proteins [199], higher transduction efficiency of viral particles utilized for gene 
therapy [198], and higher activity in ribozyme variants obtained by in vitro selection 
[200]. These reports demonstrated that deletions are not only tolerated, but can 
potentially result in improved properties, highlighting the need to consider deletions more 
frequently as a valuable source of genetic variability to be incorporated in directed 
evolution experiments. We devised a protocol capable of generating a large number of 
deletion mutants in 3-4 days. This method is ideal to routinely generate deletion libraries 
for directed evolution experiments because little optimization was required to implement 
it.  
We applied our procedure to a gene coding for an artificial RNA ligase [127,213], 
and used the resulting library of deletion variants for mRNA display selections with 
different selection pressures: 5 minutes and 60 minutes reaction time. In the ‘5 min 
selection’ we observed a decrease in percentage of bound cDNA in round 6. This result 
was unexpected and has to be confirmed by repeating round 6.  
Sequencing results of DNA from round 6 of the ‘60 min selection’ revealed the 
presence of both 13 and 18 amino acids N-terminal deletions (Figure 4.7). Despite the 
fact that we used also a double deletion library, only single deletions were found. The 
results obtained here suggest that regions other than the N-terminus cannot be deleted 
without compromising enzyme activity. However, these results might also be due to 
incomplete library coverage, as evaluated by analysis of Next Generation Sequencing 
data. Furthermore, the presence of two out of the three flexible regions suggests that 
crystallization might still be difficult. Variants with point mutations comprised 37% and 
44% of the sequences analyzed in the ‘5 min’ and ’60 min’ selection respectively. The 
most represented mutations were M35V and D43Y. While M35V is present in sequences 
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from both selections, D43Y is present only in sequences from the ‘5 min selection’, 
suggesting an important role in optimization of catalytic activity. Screening and 
characterizing the sequences isolated in these selections will assess the impact of these 
deletions and point mutations on ligase 10C activity. Furthermore, the deletion mutants 
will be screened for crystallization. 
Our data showed that the procedure presented here can generate libraries suitable 
for selections of functional deletion variants. However, sequencing results showed that 
the library still contained wild type enzyme that can potentially interfere with the 
enrichment of deletion variants. Indeed, in round 3 of the 60 minutes selection we noticed 
that a band of similar length as the wild type enzyme (332 bp) had been enriched while 
the smear containing shorter variants was disappearing. Nonetheless, gel extraction of the 
shorter variants from round 3 to round 6 in the 60 minutes selection allowed us to isolate 
active deletion variants despite the dominating presence of the wild type protein in the 
library.  
Deletion variants of a given gene have not only been used in directed evolution 
experiments to improve properties, but deletion analysis has also been invaluable for the 
biochemical characterization of proteins and ribozymes. For example deletion variants 
were generated to investigate the core sequence required to perform a certain function 
[105,200], or to remove flexible regions when crystallization proved difficult [203,204]. 
Usually these approaches require detailed structural knowledge in order to determine 
which segments could potentially be removed; however, when structures are not 
available, or in molecules with a high degree of disorder like ligase 10C [127], it is 
difficult to predict which regions can be deleted. In these cases, it is more efficient to 
generate a library of random deletions and identify functional constructs by high 
throughput assays. 
Furthermore, deletion libraries could be used to map interactions between binding 
partners: one molecule would be subjected to the deletion procedure to generate a large 
library, and the other one would be used as a bait to recover shorter variants that retain 
binding capacity. This approach, in combination with other techniques could help in 
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determining interaction surfaces and structures. For example, recently [214] such a 
multidisciplinary approach was employed to determine the structure of the yeast protein 
complex Nup84, at a resolution of 1.5 nm, by combining biochemical data obtained from 
domain deletion mapping experiments, electron microscopy data and computer modeling. 
In this study deletion constructs were individually generated one by one, based on 
available data on the domain boundaries of the complex components [214]. Generation of 
a random deletion library would be a better approach if these data were not available.   
Our protocol can also be employed for the creation of libraries of non-
homologous recombinant sequences. In this case, multiple transposition reactions should 
be performed with different target DNA sequences encoding for the parental genes. 
Alternatively, targets could be mixed in the same transposition reaction, as long as the 
fragment sub-libraries are amplified with very selective primers (step 2 in Figure 4.1).  
Our method showed some biases: a higher number of deletions at the 3' terminus 
of the target gene, and underrepresentation of longer sequences.  These biases might be 
due to preferential insertion sites at the 3' of the target gene and preferential amplification 
of shorter sequences. Previous work by others, observed that during library preparation 
for next generation sequencing, PCR amplification altered the length distribution of the 
original sample depending on the PCR system used [13]. These biases could be addressed 
either through emulsion PCR [215,216], or with different polymerase-buffer systems 
[13]. Furthermore, we cannot exclude the possibility of undersampling during the 
transposition reaction. Reaction conditions similar to ours in a previous directed 
evolution experiment [212], where a 2.6 Kb plasmid was used as a target, yielded 2,000 
insertion events. Since the insertion rate decreases with the size of the target gene 
(personal communication from the Finnzymes company), it is possible that we had much 
fewer than 2,000 insertions for our short 288 bp target. This could provide an additional 
explanation for the less than complete coverage observed. Using a more efficient 
transposase, such as Hyper MuA transposase, or conducting larger scale reactions, could 
allow for a better coverage of the library complexity.  
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In order to verify if this strategy has general applicability, we performed a 
transposition reaction and PCR amplification of the sub-libraries for two other genes, one 
coding for beta-lactamase and the other for glycerophosphoryl diester phosphodiesterase 
(GDPD) (Figure S4.3). In both cases, by using the same transposition and PCR 
conditions applied to ligase 10C, we were able to successfully amplify 3' and 5' fragment 
sub-libraries by using primers appropriate for the termini of the two target genes. In 
particular, during amplification of GDPD truncation libraries non-specific products were 
formed (around 1,000 bp for the 3' truncation library and around 100 bp for the 5' 
truncation library). The amount of these non-specific products decreased by optimizing 
annealing temperature, and in both cases the main product of the reaction was the desired 
smear, demonstrating that the procedure can be applicable to different genes. 
 4.5 Conclusions 
We provided an efficient tool for generating libraries of at least 10,000 random 
deletion mutants. We have isolated active N-terminal deletion variants of ligase 10C and 
have shown that the method presented here generates libraries suitable for directed 
evolution experiments. Given the ease of execution and general applicability, an 
engineering platform of this type will be a very useful tool for both laboratory evolution 
and characterization of proteins and functional nucleic acids, further advancing 
biochemical knowledge, and creating variants with improved properties.  
4.6 Materials and methods 
Template generation system Kit II from Finnzymes was used to perform the 
transposition reactions. TOPO TA cloning Kit and pUC19 vector (2.68 Kb) were 
purchased from Invitrogen. Phusion High Fidelity DNA Polymerase from New England 
Biolabs (NEB) was used in all PCR reactions with the buffer provided by the 
manufacturer. dNTPs stocks and restriction enzymes were purchased from NEB; primers 
were purchased from Integrated DNA Technologies (IDT), and EDTA (0.5 M, pH=8) 
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was purchased from AccuGENE. All purification kits (QIAGEN) were used according to 
manufacturer instructions. DNA concentrations were measured by reading absorbance at 
260 nm on a Nano Drop spectrophotometer 2000c (Thermo Scientific). Power Pac 300 
(Biorad) was used as power supply for gel electrophoresis, which was conducted in 0.5X 
Tris-Borate EDTA buffer (TBE); 10X TBE solution  from national diagnostics contained 
Tris Borate (0.89M) pH=8.3 and 20 mM EDTA disodium salt. DNA ladders were 
purchased from NEB. 
 
4.6.1 Amplification of pUC19 fragment, ligase 10C, transposon, beta-lactamase, and 
glycerophosphoryl diester phosphodiesterase (GDPD). 
All PCR were performed in presence of 200 µM of each deoxynucleotide, 1X 
reaction buffer, 0.5 µM of each primer, 0.01 U/ µL of Phusion high fidelity DNA 
polymerase. Reaction conditions were as follows: 3 minutes at 94°C followed by a 
variable number of cycles with 30 seconds at 94°C, 45 seconds at 55°C, and 1-3 minutes 
at 72°C depending on the product length. pUC19 fragment (pUC19* from now on) was 
amplified from 6 fM pUC19 vector  for 26 cycles in a 1 mL PCR reaction, with an 
extension time of 3 minutes. The DNA obtained was gel purified and desalted, and used 
as template for an 8 cycles PCR in the same conditions as above, but with template 
concentration of 1 nM. The target gene 10C was amplified from a vector obtained 
through TOPO TA cloning, with an extension time of 1 minute for 20 cycles. 
The transposon was amplified from the CamR3 transposon provided with the 
template generation system Kit II, with 2 minutes extension time for 24 cycles. Beta-
lactamase was amplified from a pBAD plasmid for 20 cycles with 1 minute extension 
time. GDPD was amplified from a pCA24NMAF2 plasmid [217] for 30 cycles, with 1 
minute extension time. Primers are listed in Table S1, along with the size of the PCR 
products. 
Each PCR product was gel purified and subsequently desalted using gel extraction 
and PCR clean-up Kits respectively (QIAGEN) according to manufacturer instruction. 
The transposon was subsequently digested with BglII, to create pre-cut ends for proper 
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transposition efficiency, and desalted prior to the transposition reaction. pUC19* was cut 
with BsaI, and desalted as above. 
 
4.6.2 TOPO cloning 
TOPO Cloning was performed according to manufacturer instructions, except that 
for Blue and white screening 30 µL of 30mg/mL 5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside [X-gal] were used. Cells were plated on LB-Agar containing 36µg/mL 
of Kanamycin. 
 
4.6.3 Agarose gels and electrophoresis  
All gels shown in the paper were 1% agarose. Samples were mixed with Ficoll to 
a final concentration of 2.5% prior to loading. Electrophoresis was conducted at 120V, 
for a duration variable between 30 and 50 minutes. Gels were stained with ethidium 
bromide (final concentration 0.5 ng/µL), and visualized under UV light at 254 nm. 
Staining was performed either pre-run (ethidium bromide was included in the gel prior to 
pouring), or post-run (gel was soaked in a water solution of ethidium bromide for 20 
minutes, and subsequently destained in water for 20 minutes).     
    
4.6.4 Transposition reactions 
Transposition reactions were performed using the template generation system Kit 
II from Finnzymes, according to the manufacturer’s instructions. Reactions (20 µL) were 
assembled using 12 ng of 10C DNA (64 fmoles), 20 ng of transposon (24 fmoles), 
reaction buffer to a final concentration of 1X, 220 ng of MuA transposase. The reaction 
was incubated at 30°C for 1 hour, stopped by deactivating the enzyme at 75°C for 10 
minutes, and either frozen or directly used as template for PCR. In the case where 
reaction was inhibited by addition of EDTA (final concentration 10 mM), it was heated to 
75°C for 10 minutes prior to addition of the target sequence, and then incubated at 30°C 
for 1 hour. 
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4.6.5 Library construction 
Two separate PCR reactions were carried out to generate 5' and 3' fragment sub-
libraries of 10C. Amplification was performed for 30 cycles with 200 µM of each 
deoxynucleotide, 1X reaction buffer, 0.5 µM of each primer, 0.02 U/µL Phusion 
polymerase, 0.5 µL of transposition reaction/50 µL of PCR reaction. In order to create 
the 5'-fragment sub-library the following primers were used: 
Fwd:GCGTACTTAGGCGATTAGCTGAGACCATGGACTACAAAGACGACGACGA
TAAG 
which binds the 5' end of the target gene and appends a BsaI site (underlined) 
 
Rev:  CGACATGGAAGCCATCACAAACGGCATGATGAACCTGAA  
which amplifies 904 base pairs of the transposon (position 904 to position 1). 
 
In order to create the 3'-fragment sub-library the following primers were used: 
Fwd: ACGGAAGATCACTTCGCAGAATAAATAAATCCTGGTGTC  
which amplifies 1193 base pairs from the transposon (position 109 to position 1,302) 
 
Rev:GCCAGTATAGATTGCAGCTAGGCGGTTGAGACCTTAATAGCCGGTGCCA
GATCC  which binds the 3' end of the target gene and appends a BsaI site (underlined). 
 
The two PCR products were gel purified and desalted as above. The purified 
products were both digested using BsaI to generate sticky ends compatible with the ends 
on the pUC19 fragment. DNA concentration was 100 ng/µL for the 3' fragment sub-
library, and 83 ng/µL for the 5' fragment sub-library. Each reaction contained 0.375 U/µL 
of restriction enzyme, 1X cut smart buffer (50 mM potassium acetate, 20 mM tris-acetate, 
10 mM magnesium acetate, 100 μg/ml BSA), and was incubated at 37°C for 12 hours, 
stopped by heat inactivating the enzyme at 65°C for 20 minutes, and desalted as above. 
Each purified product was simultaneously mixed with pUC19*, previously cut with BsaI, 
in a ratio higher than 1:1 (at least 4.6 pmoles of each library and 4.6 pmoles of pUC19*), 
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with the 5' fragment sub-library at a final concentration of 67 ng/µL, the 3' fragment sub- 
library at a final concentration of 84 ng/µL, pUC19* at a final concentration of 74 µg/µL, 
40U/ µL T4 DNA ligase, and 1X ligation buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM 
ATP, 10 mM DTT). The reaction was incubated at 23°C for 15 minutes. The product was 
gel purified and desalted as above, and digested with MlyI to remove the transposon 
sequences for 11 hours at 37°C in a reaction containing 15 ng/µL of ligated product, 0.3 
U/µL of MlyI and 1X cut smart buffer. The desired product was gel purified and desalted. 
The DNA was circularized by intramolecular ligation in a 50 µL reaction containing: 100 
ng DNA (2ng/µL), 40U/µL of T4 DNA ligase (Stock concentration=2,000 U/µL), and 1X 
cut smart buffer supplemented with 50 µM ATP. The reaction was incubated at 16°C 
O/N, and subsequently used as a template to amplify the final deletion library for 30 
cycles with Phusion polymerase using conditions described above. 
The library was amplified with the same primers used for the ligase 10C gene 
amplification, and the following reaction conditions were applied: 3 minutes at 94°C 
followed by 30 cycles with 30 seconds at 94°C, 15 seconds at 55°C, and 1 minute at 
72°C. The product in the range of interest (53-288 bp) was gel purified, desalted by 
ethanol precipitation and sequenced. 
 
4.6.6 Transposition and PCR amplification of fragment sub-libraries for beta-lactamase 
and GDPD 
Transposition for beta-lactamase and GDPD was carried out with the same 
conditions applied to ligase 10C, with the amount of target gene adjusted accordingly (32 
ng for GDPD and 35 ng for beta-lactamase). PCR of the sub-libraries was performed as 
described for ligase 10C, with appropriate primers for the gene termini (listed in table 
S1). 
 
4.6.7 Analysis of Next Generation Sequencing data  
Trimmomatic [218] was used to remove Illumina specific adapter contamination 
from paired 150bp long reads produced by a MiSeq. Reads that were longer than 36bp 
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and maintained their paired status (both R1 and R2 were still viable) were retained for 
downstream analysis. Paired reads were merged using usearch –fastq_mergepairs [219]. 
Reads to be merged were truncated at the first base with a quality score below 3 and 
merged reads were allowed to have up to 5 mismatches.  Once merged, the quality of the 
final sequences was evaluated and sequences with an expected error rate greater than 0.5, 
a quality reflecting more than 1 miscalled base in 2 sequences, were removed.  
Queries were aligned to the original full-length sequence using SSEARCH36 
from the FASTA36 [220,221] package using a +1/-3 match/mismatch scoring matrix and 
-1000/-1000 as gap open and gap extend penalties.  SSEARCH36 using the options above 
created high identity local alignments between the queries and the original sequences. For 
each query library pair, the extremely high gap penalties should result in two statistically 
significant alignments on either side of the deletion, by combining the two alignments the 
position and size of the deletion in each sequence can be determined. Combined 
alignments that did not include the last 10 positions of the 5' constant region and the first 
10 positions of the 3' constant regions, combined alignments that had insertions in the 
query, combined alignments that did not incorporate the entire query sequence and 
query/library pairs that did not result in exactly 2 alignments to be combined were 
removed.  The unique deletions that resulted from the alignments that met the criteria 
were then identified and used to count the number of times each position was deleted. 
The maximum theoretical number of sequences that included a deletion at a specific 
position was calculated using the following equation: 
p(N-p+1)                                                                                                           (eq.1) 
p= position deleted (bp indexed [1,N])  
N = Maximum size of deleted region (in bp) 
 
The maximum theoretical complexity was calculated using the following equation: 
(N*N/2)                                                                                                             (eq.2) 
N= Maximum size of deleted region 
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4.6.8 mRNA display selection for ligase variants 
mRNA display was performed as previously done [51,52], except that wherever 
triton was present, its concentration was increased from 0.01% to 0.25%., and AM017 
(pTTTTTTTTTTTTTTTTTTCCCAGATCC) instead of oligo BS50 was used to produce 
the reverse transcription primer. Briefly, the input DNA for each round was used as 
template for T7 transcription, the resulting RNA was purified by lithium chloride 
precipitation and cross-linked to the XL-PSO oligonucleotide bearing puromycin and 
containing an A18 tail [51,72]. The cross-linked RNA was ethanol precipitated and used 
as template for in vitro translation in reticulocyte rabbit lysate (Promega) at 30°C for 30 
minutes. Proteins were labeled with 35S-methionine for radioactive detection. Efficiency 
(E) of each step in a round of selection was calculated as follows:  
 
E= (Radioactivity of fraction/total radioactivity in the step)*100                  (eq. 3) 
 
For the first round of each selection, a 1 mL translation was performed, the 
volume was then decreased to 0.5 mL for the following rounds. The translation reaction 
was purified by oligo-dT (OdT) cellulose chromatography to remove uncrosslinked RNA 
and unfused proteins. The eluate from the OdT purification was further purified by FLAG 
affinity chromatography to remove the cross-linked but unfused RNA. The FLAG 
affinity purified fusions were reverse transcribed at 42°C for 1 hour, with the primer 
bearing the 5'-triphosphate substrate, which was produced as previously reported [51]. 
The cDNA was labeled with 32P-d-ATP for increased radioactive detection. The 
efficiency of reverse transcription was calculated by densitometry analysis on SDS 
PAGE of a sample reverse transcribed without 32P-d-ATP (‘Cold RT’ sample). Density of 
both reverse transcribed and non reverse transcribed mRNA-displayed proteins was 
measured. Total density was obtained by summing the two values. Efficiency of reverse 
transcription (ERT) was calculated according to the following equation.  
 
ERT=(Density of reverse transcribed fusions/total density)*100                      (eq.4) 
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The sample was then dialyzed 3 times against 1,000 volumes of FLAG buffer (50 
mM HEPES pH=7.4, 150 mM KCl, 0.25% Triton X-100), and purified again by FLAG 
affinity chromatography. For the first round of selection, the resulting eluate was split 
into two aliquots which were incubated for 5 minutes and 60 minutes in presence of a 
photocleavable biotinylated 3'-OH substrate and a complementary splint for the ligation 
step. The ligation was quenched with 10 mM EDTA and purified by streptavidin-biotin 
affinity chromatography as previously described, except that before incubation with the 
ImmunoPure immobilized streptavidin agarose, the reaction was mixed with urea dry 
powder to a final concentration of 8M, heated at 90°C for 3 minutes and immediately 
transferred on ice. After washing, beads were recovered with 300 μL phosphate buffered 
saline (PBS), the obtained slurry was dispensed in 100 µL aliquots in round bottom 96 
well plates, and irradiated for 15 minutes at 365 nm while shaking to release the bound 
cDNA. The released cDNA from the 5 minutes and 60 minutes selection was separately 
ethanol precipitated in presence of 1 μL glycogen (stock concentration= 20 mg/mL), 
washed with 70% ethanol, dissolved in 100 μL doubly distilled water and amplified in a 1 
mL PCR reaction using primers BS3longb'/AM016C. The two samples were separately 
used as input for the following rounds of selections with 5 minute and 60 minute 
selective pressure respectively. For each round an SDS PAGE gel (4-12% BisTris 
Acrylamide) of aliquots taken at the end of each step was run (1.5 hours, 120V) for 
quality control purposes, fixed for 10 minutes in a solution of 20% acetic acid-10% 
methanol, rinsed with distilled water for 10 minutes, dried at 80°C under vacuum for 20 
minutes, exposed overnight on a phosphor screen (GE Healthcare), and imaged on the 
scanner Storm 860 (Molecular Dynamics). The procedure was repeated for 6 rounds. 
 
4.6.9 Processing and analysis of enriched sequences from round 6 of each selection 
DNA from round 6 was cloned into a pCR-blunt-II TOPO vector, transformed 
and plated according to manufacturer instructions (Invitrogen). Plates were sent to 
Beckman Coulter for colony picking and sequencing. For both the 5 minutes and 60 
103 
minutes selection, 96 colonies were sequenced. The resulting sequences were analyzed 
with the software CLC genomics. Open reading frames were extracted by removing the 
plasmid, T7 promoter and TMV enhancer sequences by using the trimming function of 
the Next Generation Sequencing tools. Subsequently, sequences which contained tandem 
duplications, insertions and out of frame sequences were discarded after manual 
inspection of the first alignment. Upon a second alignment, sequences with internal stop 
codons and short peptides containing duplications of the 5'-terminal and 3'-terminal 
constant regions were discarded as well. The resulting set of sequences was aligned and 
inspected for the presence of deletion variants. 
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4.7 Supplementary information 
 
Figure S 4.1-Agarose gel (1%) of ligation of terminal truncation libraries to DNA linker.  
M= Marker (2 log ladder); L=ligation; (A) Product of interest: linker with sub-libraries ligated on both 
termini; (B) Linker with sub-library ligated on only one terminus. (C) Unligated fragment sub-libraries 
Ligation conditions as reported in the methods section.  
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Figure S 4.2-Agarose gel (1%) of MlyI restriction digest of ligation product.  
M= Marker (2 log ladder); RD= restriction digest with MlyI; (A) Partially digested product: only one 
transposon was removed (B) Product of interest: both transposons were removed. (C) and (D) Transposon 
sequences cleaved from the 3'and 5' fragment sub-libraries respectively 
Figure S 4.3-Agarose gel (1%) of gradient PCR of beta-lactamase and GDPD fragment sub-libraries. 
Squared brackets indicate the product of interest; •= undesired PCR products.  
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Figure S 4.4-Deletion length count for the unique sequences found in the deletion library of ligase 
10C.  
Sequence count is considered for 5 bp bins. 
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Figure S 4.5-Theoretical (red) and observed (blue) deletion counts at each potentially deleted 
nucleotide position. 
Theoretical counts were calculated as explained in the methods section; observed counts were obtained by 
aligning all the unique sequences found in the library, and counting the number of instances in which a 
certain position was deleted. 
 108 
 
Table S 4.1-Primers used for PCR amplification 
Primers are listed in the 5' to 3' direction.  The BsaI recognition site in the pUC19* reverse primer is 
underlined. The BglII recognition sites in the transposon primers are bold and underlined. Letters in lower 
case and italics in the transposon primers highlight mutations introduced to create a MlyI recognition site 
[212]. 
  
  
Amplicon Primer pair  Amplicon 
length (bp) 
pUC19* 
Fwd: CGTGTAGATAACTACGATACG 
 1,404 
Rev: 
GCTAGGCTGAGTTGCCGCTATGAGACCCTGGCCGTCGTTTTA
CAACGTCG 
Ligase 10C 
Fwd: ATGGACTACAAAGACGACGACGATAAG 
 288 
Rev: TTAATAGCCGGTGCCAGATCC   
 
Transposon 
Fwd and Rev: 
GCTTAGATCTGActCGGCGCACGAAAAACGCGAAAG 
 
1,320 
Βeta-
lactamase 
Fwd: ATGAGTATTCAACATTTCCG 
 874 
Rev: CGTTCCATGGTTATTACCAATGCTTAATCAGTGAGG 
 
GDPD Fwd: AAAGAGGAGAAATTACATATGGGCAGCGATAAGATC 
 
 
809 
Rev: GTTAGCGATGTACATTAATAGCCGGTGCCAGATCC 
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Chapter 5 : Towards the selection of artificial RNA ligases from a 
library of entirely random polypeptides  
This chapter describes unpublished experiments aimed at selecting an artificial 
RNA ligase activity from a random library by mRNA display. I performed all the 
experiments, and Dr. Seelig and I analyzed the results.  
5.1 Summary 
Early functional proteins presumably arose form random peptide sequences, 
which subsequently evolved for improved structure and increased performance. Several 
studies, both in silico and in vivo focused on testing random libraries for the presence of 
folded and functional proteins. While proteins with binding activities have successfully 
been isolated from random peptide libraries, there has been no report on the selection of 
protein enzymes from random sequence space. In this chapter we will present our 
attempts to select an RNA ligase from a random library by mRNA display. Any active 
variant isolated in this selection will be compared to ligase 10C. The long term goal of 
the lab is to characterize and compare structure and mechanism of enzymes that catalyze 
the same reactions, but from different origins, to identify potential evolutionary 
pathways.    
5.2 Introduction 
In extant cells, proteins perform various functions: regulation of intra and inter 
cellular communication, transport of molecules across the membrane and between the 
cellular compartments, maintenance of structural integrity, and catalysis of biochemical 
reactions. The folding and functionality of natural proteins depend on their primary 
amino acid sequence. However, extant proteins represent only a very small fraction of the 
vast number of all possible polypeptides that are referred to as the protein sequence space 
[222,223]. For example, it has been calculated that the ratio of natural proteins to all 
possible sequences, is similar to the ratio of the size of a hydrogen atom and the size of 
the Universe [103]. Given the size of sequence space, natural evolution can only ever 
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sample an extremely small subset of possible sequences for functional proteins [103]. 
This observation raises the question of how early functional polypeptides were selected 
and evolved. 
It has been proposed that the earliest functional proteins originated from random 
polypeptides [103,224]. For example, it has been shown at the sequence level that residue 
distribution in natural proteins follows a random pattern based on properties such as 
hydrophobicity, charge, volume and secondary structure propensity, except for amino 
acids with a propensity for forming α-helices, which tend to cluster together [224-226].  
In addition, a set of random proteins generated computationally and a set of 
natural proteins were compared for secondary structural content in silico [102]. For both 
sets the total content was over 60%. Furthermore, tertiary structural simulations for 6 
sequences picked randomly from the set generated computationally revealed ordered 
structures, suggesting that a high fraction of the random polypeptides was folded.  
Various studies addressed experimentally the questions of whether soluble and 
folded proteins could be found in random sequence space. Within libraries of random 
polypeptides  of 95 amino acids [227] and 70 amino acids in length [228], it was found 
that 20% of the analyzed clones are soluble in E.coli lysate [227] and that 20% are folded 
[228] by using resistance to proteolysis as folding criterion. In another study [229], 
random decapeptides synthesized by Merrifield synthesis, were subjected to cycles of 
condensation and selection for solubility under certain conditions of pH, salinity and 
temperature, to finally obtain a 44 residue random peptide, soluble in water with 49% α-
helix, 12% β-sheet, and 39% random coil, as determined by circular dichroism. Other 
studies showed that random proteins can substitute domains of natural proteins without 
disrupting functionality [230] and that random elongation mutagenesis resulted in 
increased thermal stability of natural enzymes [231].  
The above-mentioned studies focused on solubility and structure. However in 
order to consider the hypothesis of enzymes originated from random sequences plausible, 
there is the need for experimental evidence that random proteins can be functional and 
evolvable. Several articles support this idea by showing that random proteins can be 
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evolved for solubility [232], for DNA binding [233], and that unstructured random 
proteins can develop secondary structural elements within the process of selection for 
DNA binding [234]. 
The most striking result was obtained by Keefe and Szostak [105]. They 
identified novel ATP binders from a library of 6 x 1012 random polypeptides using the 
mRNA display in vitro selection method. The identified binders have no sequence and 
structural counterpart in nature, as assessed by crystallography [106]. This work 
estimated the frequency of functional ATP-binding proteins to be 1 in 1011 random 
sequences. 
Esterase activity towards p-nitrophenyl acetate was previously observed by 
sampling a small number random polypeptides [108-110], and in a random binary 
patterned library capable of forming alpha helices [110]. However, the ester hydrolysis of 
p-nitrophenyl acetate has been shown many times to be particularly easy to catalyze even 
by non-enzyme proteins. Therefore, this reaction is considered a poorly suited benchmark 
to study the evolution of enzymatic activity from random sequence space [107]. 
Indeed all the results above showed that random proteins are capable of folding 
into tertiary structures and evolve to perform different functions, which is mainly 
binding. However the selection of an efficient catalytic activity from an entirely random 
library has not been reported to date. The goal of my project was to investigate whether a 
completely novel enzymatic activity could be selected from an unbiased random library, 
which neither had been evolved for substrate binding, nor contained any predetermined 
secondary structure patterns. This would lend support for the hypothesis that the first 
enzymes could have arisen from random sequences. If successful, this would also open 
new avenues for the selection of novel enzymatic activities for practical applications. 
The long-term goal for this line of research envisions to compare the enzymes 
selected from the scaffold library [51] with enzymatic activities that might result from the 
random library. These studies will give insight into different solutions available for a 
catalytic problem, and how these compare to each other, and will potentially provide a 
simple system to investigate mechanisms of convergent evolution. 
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5.3 Results 
In order to perform this experiment, we applied the same selection procedure used 
previously [51], selecting for the same activity of a 5'--triphosphate-dependent RNA 
ligase. However, instead of starting from the scaffold library, we used a random library 
previously synthesized [37], which had also been successfully used for the selection of 
ATP binders [105]. 
The random region of the mRNA display library is framed by constant regions 
needed to produce and purify the mRNA-displayed proteins, and to amplify the cDNA 
obtained at the end of each round [52]. The enhancer sequence is also used for as binding 
site for the forward primer. The previously selected RNA ligase [127,213] had been 
manipulated in our laboratory and it has the same enhancer as the random library 
[37,105]. In order to avoid contamination we substituted the original Tobacco Mosaic 
Virus sequence with an Alfalfa Mosaic Virus sequence by PCR before starting the 
selection procedure. Successful change was confirmed by TOPO Cloning the resulting 
DNA and sequencing 5 random clones (Figure S5.1). 
The mRNA display procedure was carried out for 13 rounds of cycles of selection 
and amplification as reported previously [51,52] and as outlined in section 4.6.8. The 
percentage of cDNA bound to the streptavidin beads was calculated with equation 3 in 
section 4.6.8 to monitor the progress of the selection.  
Prior to starting the selection, we performed pilot experiments to ensure that the 
efficiency of all the steps was comparable to results reported previously [52] . Different 
from the previous method, we slightly changed the streptavidin-biotin affinity 
chromatography procedure to increase the binding efficiency by subjecting fusions to 
heat denaturation for 3 minutes at 90°C in presence of 8M urea. A mock selection with a 
positive control of ligation showed that the denaturing treatment increased the percentage 
of binding to 38.3%, compared to the sample treated as in the previous protocol (25.8%), 
while a negative control gave a background binding of 0.08%. The positive control was 
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obtained by reverse transcribing purified mRNA-displayed proteins with a primer 
attached to a pre-ligated biotinylated product. This primer will be called 66 mer 
throughout this chapter. 
To assess quality of the samples mRNA-displayed proteins were analyzed by SDS 
PAGE (Figure 5.1). The samples taken after Oligo-dT-cellulose purification and FLAG 
purification contained purified fusions as expected (Figure 5.1, compare ‘TL’ lane to 
‘OdT’ and ‘FLAG’ lanes). In presence of 32P-α-dATP, a secondary band at a lower 
molecular weight was observed. This band corresponded to cross-linked RNA not fused 
to protein which apparently had not completely been removed during the first FLAG 
purification procedure. The second FLAG purification process (Flag II) efficiently 
removed this band. Finally, when fusions were incubated with 8M urea at 90°C 
(‘Rxn+urea+90°C’), two bands of lower electrophoretic mobility were observed. These 
bands likely represent an mRNA cDNA complex formed by re-annealing of only the 
constant terminal regions, and cDNA alone. 
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Figure 5.1-Autoradiogram of SDS PAGE gel analyzing individual steps during a typical round of 
selection.  
TL: translation; OdT: eluate from oligo-(dT) cellulose chromatography; Flag: eluate from Flag affinity 
purification; Cold RT: reverse transcription without 32P-α-dATP; Hot RT: reverse transcription with 32P-α-
dATP; Dialysis: sample recovered after dialysis in Flag buffer; Flag II: eluate from second Flag affinity 
purification; Rxn+UREA: quenched overnight ligation mixed with 8 M urea; Rxn+UREA+90°C: like 
previous sample, then heated at 90°C for 3 minutes and chilled on ice; SA FT: flow-through of streptavidin 
biotin affinity chromatography. 
 
 
The progress of the in vitro selection was monitored by calculating the percentage 
of cDNA bound to the streptavidin resin at the end of each round. In any immobilization, 
a certain level of background binding is observed, which was around 0.1% for this 
selection. Figure 5.2 shows that no substantial increase of the signal over background was 
achieved after any of the rounds of selection, suggesting that no active sequences were 
enriched. In order to further test this assumption, cDNA isolated after round 13 was 
cloned by TOPO TA cloning and 96 individual colonies were sequenced. In total, 92 
colonies gave good quality data and 83 sequences coded for in frame proteins. An 
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alignment of these 83 protein sequences (Figure S5.2 and Figure S5.3) revealed three 
major families: I, II and III, with family III comprising the largest number of sequences 
(30/83) (Figure S5.2-Figure S5.6). Six additional duplicated sequences and 17 single 
sequences were also present. 
 
 
Figure 5.2-Selection progress.  
The percentage of 32P-labelled cDNA bound to the streptavidin Agarose resin at the end of each round 
monitored. No substantial increase of the signal over background was observed. 
 
Eleven sequences, one chosen from each family and from several of the duplicate 
sequences were individually subjected to one round of selection. Their activity was tested 
by a gel shift mobility assay. Incubation of the ligation reaction with streptavidin resulted 
in a cDNA band with reduced mobility if the clone was active. None of the clones 
showed a shift, indicating that they were not active (Figure 5.3). As a positive control 
experiment, we reverse transcribed clones A5 and a mix of clones F2/F3/F9 with the 66 
mer primer. Both A5 (gel A) and clones F2/F3/F9 (gel B) showed a shift when reverse 
transcribed with a positive control primer. The shift was not observed when streptavidin 
was not included (sample labeled as –SA), indicating that it was specifically due to 
binding of streptavidin to the biotinylated cDNA. An active RNA ligase (clone 13, gel B) 
from the previous selection [51] was used as an additional positive control for the 
reaction conditions. This clone in presence of streptavidin showed a shifted cDNA band, 
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indicating that it was active in the experimental conditions. Results were further validated 
by incubating clone 13 and sequence F9 from round 13 with ligation substrate and then 
subjecting them to the entire streptavidin biotin affinity chromatography procedure. 
Incubation of clone 13 with streptavidin resin resulted in 0.69% of the total radioactivity 
bound to the resin consistent with activity, while for F9 only 0.05% of the total 
radioactivity bound to the resin, and was indistinguishable from the percentage of 
background that bound when biotinylated substrate was not added to the reaction 
(0.06%).  
  
 
Figure 5.3-Gel shift assay to test ligase activity of clones isolated after round 13.  
All samples were incubated with streptavidin otherwise indicated by (-SA). (A) Clones A5, A8, and B7 are 
unrelated sequences that were found twice in the alignment; Clones C6, C8 and D1 belonged to family II; 
Pool Rd 13 referred to the cDNA mixture after round 13. Clone A5 was also reverse transcribed with a 
positive control primer (66 mer) to verify binding of the biotinylated cDNA to streptavidin in the 
experimental conditions. (B) Clone D6 was found twice in the alignment; clones F2, F3 and F9 belong to 
family III, clone H3 belongs to family I. Clone 13 is an active ligase from a previous selection [51], and 
was used as positive control for reaction conditions; the dot indicates biotinylated cDNA, and the asterisk 
marks the shifted biotinylated cDNA. A mixture of clones F2/F3/F9 was also reverse transcribed with a 
positive control primer (66 mer) to verify binding of the biotinylated cDNA to streptavidin in the 
experimental conditions. 
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5.4 Discussion 
The detailed analysis of the cDNA isolated after 13 rounds of selection indicated 
that no active ligase enzymes were enriched during the selection procedure. It is 
impossible to determine with confidence the reason for this negative result, however 
different potential reasons will be discussed in the following.   
There is a possibility that the lack of enrichment of ligase enzymes was due to 
technical reasons such as biases in all but the selection step that could favor the 
enrichment of sequences by properties other than ligation activity. This hypothesis is 
supported by the fact that in round 13 three sequence families were observed, but upon 
screening of individual clones none of them showed activity. These sequences were 
clearly enriched. Those enrichment biases could be for example preferential transcription, 
translation, enhanced affinity to oligo(dT) or Flag resin, preferential reverse transcription 
or PCR amplification. Those inadvertently enriched sequences were then non-specifically 
carried through the streptavidin-biotin affinity chromatography step as a background. In 
particular, family II possesses two FLAG peptide motifs, and family I possesses a partial 
FLAG motif such as DYK, suggesting enrichment during the FLAG affinity 
chromatography step. 
Another possibility is that the library does not contain active ligases. The 
selection of an enzymatic activity might require sampling of a larger library. Another 
potential reason for failing to find active enzymes is that different reaction conditions are 
needed to select for active RNA ligases. In order to explore this possibility, we are 
currently performing another selection, in presence of metal cofactors to aid folding 
and/or catalysis. Previous mRNA display selections have shown that metal coordination 
provides structural organization and supports functionality in the context of unbiased 
libraries [105], or in the context of randomized scaffold libraries [51], even when most of 
the structural information carried by the parent protein is lost and replaced by disordered 
regions [127].  
 
 118 
 
5.5 Conclusions 
Our selection did not yield active ligase variants. While multiple factors could 
have contributed to this, our current focus is on testing different reaction conditions. I am 
repeating the selection in presence of metal cofactors, which could facilitate folding 
and/or catalysis. Furthermore, it would be desirable to reduce the apparent bias for 
enhanced Flag binding by modifying the selection procedure. 
 
 
 
 
5.6 Materials and methods 
All chemicals were purchased from Sigma-Aldrich unless otherwise stated. 
 
5.6.1 PCR amplification of input DNA for round 1 and subsequent rounds. 
All chemicals for PCR were purchased from NEB, primers were synthesized by 
IDT, and Taq Polylmerase was expressed in house and purified by Ni-NTA 
chromatography. 
DNA for round 1 was amplified by PCR in a 40 mL reaction, from a previously 
synthesized random library [37,105]. The template concentration was 6.4 nM, and the 
amplification was carried out for 5 cycles in presence of deoxynucleotides (200 μM each) 
Taq Polymerase (1.08 U/μL), 1X Thermopol buffer [20 mM Tris-HCl, 10 mM 
(NH4)2SO4, 10 mM KCl, 2 mM MgSO4 0.1% Triton® X-100, pH 8.8 at 25°C], and 
primers BS97 and BS24B (0.5 μM each). Thermal cycling comprised three steps: 94°C 
for 30 seconds, 55°C for 45 seconds, 72°C for 1 minute, except for first cycle where 
temperature was held at 94°C for 3.5 minutes. Primer BS97 replaced the TMV enhancer 
sequence with an AMV enhancer sequence. DNA obtained from subsequent rounds of 
selection was instead amplified with primers BS98B and primers BS24B’. Primer BS98B 
binds to the AMV enhancer sequence. 
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5.6.2 Purification of PCR products 
DNA for the first and subsequent rounds input DNA was purified by extracting 
the PCR reaction with one volume of phenol, followed by extraction of the phenol phase 
with half a volume of water. The aqueous phase was combined, extracted with three 
volumes of chloroform, concentrated by mixing with butanol, and ethanol precipitated. 
The resulting pellet was dissolved in TE buffer (10mM Tris pH=8, 1 mM EDTA). 
Separation of the organic and aqueous phase during purification of the DNA for the first 
round was obtained by centrifugation at 3,000 rpms, for 10 minutes at 25°C, in 50 mL 
conical tubes, due to the large volume of the PCR reaction (40 mL). In subsequent rounds 
centrifugation was performed at 1,000 rpms for 30 seconds at 25°C in 1.5 mL tubes.   
  
5.6.3 mRNA display selection for ligase enzymes 
mRNA display was performed as previously [51], and as reported in section 4.6.8. 
except for differences reported here. Zinc Chloride and 2-mercaptoethanol were omitted 
from the buffers, and wherever Triton was present its concentration was increased from 
0.01% to 0.25%. RNA was purified by electro elution for 2 hours at 300 V and 
concentrated by ethanol precipitation. 
For the first round a 10 mL translation was performed. For rounds 2-6, the volume 
was decreased to 2 mL, and for rounds 7-13 to 1 mL. After reverse transcription the 
sample was dialyzed 3 times against 1,000 volumes of FLAG buffer, (50 mM Hepes 
pH=7.4, 150 mM KCl, 0.25% Triton X-100), and purified by a second FLAG affinity 
chromatography. Ligation reaction was performed for 16 hours. At the end of the first 
round of selection, the streptavidin agarose resin was used directly as template for PCR 
amplification (50 μL agarose/ mL PCR). In following rounds the cDNA was eluted by 
photocleavage in 300 μL phosphate buffered saline (PBS), ethanol precipitated in 
presence of 1 μL glycogen (stock concentration= 20 mg/mL), washed with 70% ethanol, 
dissolved in 100 μL doubly distilled water and amplified in a 1 mL PCR reaction using 
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the primers BS98B/BS24B’. SDS PAGE gel electrophoresis, gel fixation and imaging 
were conducted as in section 4.6.8. The procedure was repeated for 13 rounds. 
5.6.4 TOPO TA cloning 
TOPO TA Cloning was performed according to manufacturer procedures. For 
high-throughput sequencing purposes DNA from round 13 was treated as follows to 
increase cloning efficiency. The PCR product, previously purified by phenol/chloroform 
extraction and ethanol precipitation was incubated with dATP (200 μM), Thermo Pol 
buffer (1X), and Taq Pol (0.022 U/ μL) at 72°C for 15 minutes, purified by 
Phenol/Chloroform extraction and ethanol precipitation and gel purified with a 
commercial kit (QIAGEN) according to manufacturer guidelines. Cloning reaction was 
kept at 25°C for 30 minutes. TOP 10 chemically competent cells (Invitrogen) were 
transformed with Half of the reaction (3 μL). After 1 hour recovery in SOC media at 
37°C, cells were spread on LB/Kanamycin (36 μg/ μL) plate, previously spread with 5-
bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) for blue white screening. 
5.6.5 Sequencing of individual colonies 
Plate obtained from TOPO TA cloning were sent to Beckman Coulter for colony 
picking, plasmid purification and sequencing.   
5.6.6 Analysis of sequencing results 
Sequencing results were analyzed with the  Clone Manager, Bio edit and Clustal 
W software [235].  
5.6.7 Ligation activity assay of mRNA-displayed proteins by gel shift 
The sequences chosen for screening were PCR amplified by using primers BS98B 
and BS24B’, and each sequence was individually mRNA-displayed as outlined above, 
until the dialysis step. Dialyzed fusions were incubated overnight with 3'-OH biotinylated 
substrate and splint.  The ligation reaction was quenched with 3 volumes of loading 
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buffer (8 M urea, 5% glycerol, 6.5 mM EDTA), heated at 94°C for 3 minutes, transferred 
immediately on ice and then mixed with an excess of streptavidin. Results were analyzed 
by 4% denaturing UREA PAGE.         
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5.7 Supplementary information 
 
Figure S 5.1- Sequences of 5 randomly chosen clones from input DNA for first round of selection, after performing TOPO TA Cloning.  
As expected, all five clones contained the terminal constant regions framing the 80 amino acid random region. The four constant ACTG regions in the random 
region are left-over restriction and ligation sites to enable the library construction from sub-libraries of 20 random amino acids fragments [37].   
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Figure S 5.2-Part I of alignment of protein sequences isolated after round 13.  
This part of the alignment shows 51 out of 83 total sequences, and includes family I and II. Family I comprised 6 nearly identical sequences (7% of the total) and 
family II comprised 18 closely-related sequences (22% of the total). Family II contained a duplication of the FLAG peptide motif (MDYKDDDDK) starting at 
position 16. 
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Figure S 5.3-Part II of alignment of protein sequences from round 13.  
This part of the alignment shows 32 out of 83 total sequences and included family III which comprised 30 sequences (36% of the total). 
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Figure S 5.4-Family I from round 13. 
 
 
 
 
Figure S 5.5-Family II from round 13.  
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Figure S 5.6-Family III from round 13 
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Chapter 6 : Conclusions and future directions 
Several de novo enzymes have been generated by computational design and in 
vitro directed evolution. While artificial enzymes hold great potential to expand the type 
of biocatalytic reactions available for industrial and research purposes, they are usually 
slower than natural enzymes. For example, ligase 10C has a turnover of less than 1 per 
hour. It is therefore crucial to improve the efficiency of these enzymes through 
engineering and evolution. In-depth studies of their structural and functional properties 
will enable us to generate better de novo enzymes in the future.  
This thesis focused on the structural and biochemical characterization of the 
artificial RNA ligase 10C. In chapter 3, we solved the structure of ligase 10C by NMR 
and found that the enzyme had an unusually dynamic fold. While the protein is folded, it 
surprisingly lacked secondary structure elements such as α-helices and β-strands. It has 
been suggested that for example viral proteins are more evolvable than proteins with a 
tightly packed hydrophobic core, because they can accept more mutations due to their 
flexibility and lack of inter-residue connectivity [144]. Similarly, the flexible structure of 
ligase 10C could be highly evolvable, and therefore used as a model to study the 
optimization of primordial catalysts as ligase 10C had not been subjected to billions of 
years of selection and evolution like modern enzymes. Therefore, future studies in the 
Seelig lab will include further improvement of the catalytic activity of ligase 10C.  
Ligase 10C is active at 65°C and thermostable with a melting temperature of 
72°C, despite its dynamic structure. We compared the enzyme to two mesophilic ligase 
variants, selected at 23°C. In particular, sequence analysis of ligase 10C and the most 
closely related mesophilic variant ligase #7 suggested that the increased stability of ligase 
10C is due to several point mutations and a 13 amino acids deletion which favors inter-
residue interactions between the two termini. Furthermore, in contrast to the notion that 
there is a trade-off between enzyme stability at high temperatures and activity at lower 
temperatures, ligase 10C is more active at 23°C than at 65°C.  
We have so far been unable to crystallize ligase 10C likely because it contains 
three flexible regions, namely at both termini and in an internal loop. We hence generated 
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a library of random deletions variants of ligase 10C and subjected it to six rounds of 
mRNA display selection to identify shorter variants, predicting that deletion of some 
flexible regions could facilitate crystallization. We isolated two variants with deletions of 
13 and 18 amino acids near the N-terminus of the enzyme, which now need to be tested 
for crystallization. Yet, as two of the three flexible regions are still present in those 
variants, crystallization might continue to be a challenge. Through the in vitro selection 
we also identified several other variants with point mutations suggesting that these 
substitutions had a neutral or potentially a beneficial effect on activity. We will express 
the deletion mutants and the variants with point mutations individually as mRNA 
displayed proteins, screen them for activity, and use the most active clones for further 
characterization as purified free proteins.  
The power of Next Generation Sequencing (NGS) data analysis could be 
exploited to facilitate the engineering of enzymes by directed evolution. For example, 
DNA from individual rounds of a selection for a Diels-Alderase ribozyme, was recently 
sequenced by NGS [236]. The analysis showed a good correlation between increased 
selective pressure and enrichment of substitutions at certain positions. These positions 
had been previously identified as important catalytic residues in structure-function 
relationship studies [236]. These results suggest that NGS data analysis could also be 
used to identify key target residues in ligase 10C for further directed evolution 
experiments. This type of approach would be particularly useful as detailed structural or 
biochemical information about the catalytic active site might be difficult to acquire. 
We also performed a selection for RNA ligase enzymes from a completely 
random library, although no active enzymes have been enriched yet. Our long-term goal 
with this project is to characterize and compare future enzymes isolated from the random 
library to ligase 10C, in order to explore how different evolutionary solutions to the same 
catalytic problem might relate. We are now repeating this selection while using modified 
conditions. We included a number of divalent metal ions to the reaction with the 
hypothesis that these could potentially function as cofactors to aid folding and catalysis. 
This project is currently underway and therefore not reported here in more detail. 
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Ligase 10C was the first de novo enzyme obtained using a generalizable selection 
scheme for the isolation of enzymes by mRNA display However, enzymes for other bond 
forming reaction could be selected by following a similar strategy. The only requirement 
is the ability to modify substrates so that bond formation can be coupled to binding onto a 
solid support for purification purposes [51]. 
Furthermore, enzymes that catalyze bond-breaking reactions could be selected 
with mRNA display. In this case, the mRNA-displayed protein library would be 
immobilized onto a solid support via the substrate, and the cDNA released upon bond 
breaking would be amplified by PCR as input for the next round of selection [35]. 
Finally, mRNA display could be employed for the selection of enzymes which induce 
structural rearrangements, such as isomerases, oxidoreductases or transferases. In that 
case, selection can be achieved by using product-specific affinity reagents such as an 
antibody that binds to the reaction product but not the substrate. 
The selection of de novo enzymes by in vitro directed evolution is still in its 
infancy, but here we have clearly shown that the method is powerful and versatile. In 
particular, we demonstrated an enzyme selection at high temperature, but other 
conditions such acidic or basic pHs, or organic solvents could be applied, as long as the 
RNA is not degraded. Previous experience with de novo enzymes obtained by 
computational design showed that further directed evolution can lead to 1,000 fold 
improvements in Kcat/Km. Ligase 10C also has a relatively low activity, however 
additional rounds of directed evolution with methods that can directly select for multiple 
turnovers, such as in vitro compartmentalization, hold great potential to obtain improved 
catalysts. Despite the fact that de novo enzymes have so far shown only modest levels of 
activity, they provide a good starting point for further evolution when a suitable activity 
cannot be found in nature. Hence, in the future, artificial enzymes will expand the range 
of reactions addressed by biocatalysis.  
One of the main goals for the future in the Seelig lab is to perform other selections 
to further demonstrate the capabilities of the method, and also to evolve ligase 10C for 
increased activity to demonstrate the catalytic potential of artificial enzymes. Projects to 
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achieve these goals are now underway. This will encourage a more extensive use of 
mRNA display for enzyme selection in the scientific community, and eventually lead, in 
combination with other technological innovations such as NGS and microfluidics, to a 
platform for the development of artificial catalysts with custom properties for both 
industrial and research purposes. 
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